Record NNP NNP O
date NN NN O
: : : O
2080-05-30 NN NN I-DATE
CC NNP NNP O
. . . O
: : : O
fever NN NN O
HPI NNP NNP O
. . . O
: : : O
70 CD CD I-AGE
y/o NN NN O
Chilean JJ JJ I-COUNTRY
woman NN NN O
with IN IN O
PMH NNP NNP O
DM NNP NNP O
, , , O
HTN NNP NNP O
, , , O
high JJ JJ O
cholesterol NN NN O
who WP WP O
was VBD VBD O
recently RB RB O
admitted VBN VBN O
to TO TO O
CMC NNP NNP I-HOSPITAL
ED NNP NNP O
obs NN NN O
unit NN NN O
( ( ( O
last JJ JJ O
week NN NN O
) ) ) O
for IN IN O
back RB RB O
pain NN NN O
. . . O
She PRP PRP O
. . . O
has VBZ VBZ O
been VBN VBN O
taking VBG VBG O
oxycodone NN NN O
and CC CC O
muscle NN NN O
relaxants NNS NNS O
at IN IN O
home NN NN O
. . . O
The DT DT O
. . . O
past JJ JJ O
few JJ JJ O
days NNS NNS O
, , , O
she PRP PRP O
has VBZ VBZ O
had VBN VBN O
fevers NNS NNS O
every DT DT O
afternoon NN NN O
and CC CC O
family NN NN O
is VBZ VBZ O
concerned VBN VBN O
about IN IN O
malaria NN NN O
. . . O
Fevers NNP NNP O
. . . O
at IN IN O
home NN NN O
have VBP VBP O
been VBN VBN O
between IN IN O
103 CD CD O
and CC CC O
105 CD CD O
( ( ( O
measured VBN VBN O
with IN IN O
thermometer NN NN O
) ) ) O
. . . O
She PRP PRP O
. . . O
continues VBZ VBZ O
to TO TO O
have VB VB O
back RB RB O
pain NN NN O
and CC CC O
also RB RB O
has VBZ VBZ O
abdominal JJ JJ O
pain NN NN O
, , , O
decreased VBD VBD O
appetite NN NN O
. . . O
Per IN IN O
. . . O
family NN NN O
, , , O
she PRP PRP O
has VBZ VBZ O
not RB RB O
seemed VBN VBN O
confused VBN VBN O
at IN IN O
all DT DT O
. . . O
Of IN IN O
. . . O
note NN NN O
, , , O
she PRP PRP O
has VBZ VBZ O
had VBN VBN O
malaria NN NN O
in IN IN O
the DT DT O
past JJ JJ O
, , , O
and CC CC O
she PRP PRP O
reports VBZ VBZ O
the DT DT O
symptoms NNS NNS O
are VBP VBP O
the DT DT O
same JJ JJ O
now RB RB O
as IN IN O
they PRP PRP O
were VBD VBD O
at IN IN O
that DT DT O
time NN NN O
. . . O
Problems NNS NNS O
. . . O
( ( ( O
per IN IN O
LMR NNP NNP O
) ) ) O
Diabetes NNP NNP O
. . . O
mellitus NN NN O
: : : O
dx NN NN O
late JJ JJ O
2060s CD CD I-DATE
. . . O
No DT DT O
. . . O
h/o NN NN O
macro NN NN O
or CC CC O
microvascular NN NN O
complications NNS NNS O
. . . O
Hypertensive NNP NNP O
. . . O
disorder NN NN O
: : : O
dx NN NN O
2060s NN NN I-DATE
, , , O
was VBD VBD O
taking VBG VBG O
atenolol NN NN O
, , , O
enalapril NN NN O
and CC CC O
isosorbide NN NN O
in IN IN O
UNITED NNP NNP I-COUNTRY
KINGDOM NNP NNP I-COUNTRY
Hypercholesterolemia NNP NNP O
. . . O
Obesity NNP NNP O
. . . O
Osteoarthritis NNP NNP O
. . . O
: : : O
L NNP NNP O
knee NN NN O
worst JJS JJS O
spot NN NN O
Gastroesophageal NNP NNP O
. . . O
reflux NN NN O
disease NN NN O
: : : O
x SYM SYM O
years NNS NNS O
, , , O
never RB RB O
had VBD VBD O
EGD NNP NNP O
. . . O
H. NN NN O
. . . O
pylori NN NN O
serology NN NN O
+ NN NN O
Helicobacter NNP NNP O
. . . O
pylori NN NN O
: : : O
serology NN NN O
positive JJ JJ O
2068 CD CD I-DATE
and CC CC O
re-check NN NN O
2/2080 CD CD I-DATE
, , , O
no DT DT O
Ag NNP NNP O
done VBN VBN O
. . . O
Given VBN VBN O
. . . O
triple NN NN O
therapy NN NN O
Rx NNP NNP O
by IN IN O
Internal NNP NNP O
Medicine NNP NNP O
Vitamin NNP NNP O
. . . O
D NNP NNP O
deficiency NN NN O
Hepatitis NNP NNP O
. . . O
B NNP NNP O
antibody NN NN O
present JJ JJ O
: : : O
Had VBD VBD O
HbsAg NNP NNP O
+ NN NN O
and CC CC O
HbsAb NNP NNP O
+ NN NN O
in IN IN O
2067 CD CD I-DATE
. . . O
LFTs NNP NNP O
. . . O
wnl NN NN O
2067 CD CD I-DATE
and CC CC O
2080 CD CD I-DATE
. . . O
Positive NNP NNP O
. . . O
PPD NNP NNP O
: : : O
dx NN NN O
in IN IN O
Mississippi NNP NNP I-STATE
previously RB RB O
in IN IN O
2067 CD CD I-DATE
Osteoporosis NNP NNP O
. . . O
Medications NNP NNP O
. . . O
( ( ( O
per IN IN O
LMR NNP NNP O
) ) ) O
Aspirin NNP NNP O
. . . O
( ( ( O
ACETYLSALICYLIC NNP NNP O
Acid NNP NNP O
) ) ) O
81 CD CD O
MG NNP NNP O
( ( ( O
81 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take VB VB O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#30 NN NN O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
Atenolol NNP NNP O
. . . O
50 CD CD O
MG NNP NNP O
( ( ( O
50MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#30 NN NN O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
Calcium NNP NNP O
. . . O
600mg CD CD O
+ NN NN O
Vitamin NNP NNP O
D(400IU) NNP NNP O
1 CD CD O
TAB NNP NNP O
PO NNP NNP O
BID NNP NNP O
#60 NN NN O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
Ergocalciferol NNP NNP O
. . . O
50000 CD CD O
UNITS NNP NNP O
( ( ( O
50000 CD CD O
UNIT NNP NNP O
CAPSULE NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QWEEK NNP NNP O
x SYM SYM O
42 CD CD O
days NNS NNS O
#6 NN NN O
Capsule NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
Lisinopril NNP NNP O
. . . O
20 CD CD O
MG NNP NNP O
( ( ( O
20 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take VB VB O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#30 NN NN O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
Metformin NNP NNP O
. . . O
500 CD CD O
MG NNP NNP O
( ( ( O
500 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take VB VB O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#60 NN NN O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
Motrin NNP NNP O
. . . O
( ( ( O
IBUPROFEN NNP NNP O
) ) ) O
600 CD CD O
MG NNP NNP O
( ( ( O
600MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
Q6H NNP NNP O
PRN NNP NNP O
pain NN NN O
, , , O
Take VB VB O
with IN IN O
food NN NN O
x SYM SYM O
7 CD CD O
days NNS NNS O
#28 NN NN O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
Nulytely RB RB O
. . . O
4000 CD CD O
ML NNP NNP O
PO NNP NNP O
as IN IN O
directed VBN VBN O
#1 NN NN O
Bottle NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
Oxycodone NNP NNP O
. . . O
5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
Q6H NNP NNP O
PRN NNP NNP O
pain NN NN O
, , , O
pain NN NN O
not RB RB O
relieved VBN VBN O
by IN IN O
ibuprofen NN NN O
Simvastatin NNP NNP O
. . . O
40 CD CD O
MG NNP NNP O
( ( ( O
40 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take VB VB O
1 CD CD O
) ) ) O
PO NNP NNP O
QPM NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#30 NN NN O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
Valium NNP NNP O
. . . O
( ( ( O
DIAZEPAM NNP NNP O
) ) ) O
5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
Q8H NNP NNP O
, , , O
Take NNP NNP O
1 CD CD O
tablet NN NN O
every DT DT O
8 CD CD O
hours NNS NNS O
for IN IN O
muscle NN NN O
relaxation NN NN O
if IN IN O
awake/uncomfortable JJ JJ O
Allergies NNP NNP O
. . . O
NKA NNP NNP O
. . . O
Social NNP NNP O
. . . O
History NN NN O
Here RB RB O
. . . O
with IN IN O
several JJ JJ O
family NN NN O
members NNS NNS O
. . . O
Originally RB RB O
. . . O
from IN IN O
Chile NNP NNP I-COUNTRY
, , , O
does VBZ VBZ O
not RB RB O
speak VB VB O
English NNP NNP O
. . . O
Physical JJ JJ O
. . . O
Exam NNP NNP O
102.6 CD CD O
. . . O
, , , O
HR NNP NNP O
102 CD CD O
, , , O
RR NNP NNP O
20 CD CD O
, , , O
99 CD CD O
% NN NN O
RA NNP NNP O
BP NNP NNP O
. . . O
184/68 CD CD O
and CC CC O
178/69 CD CD O
General NNP NNP O
. . . O
- : : O
Very RB RB O
uncomfortable JJ JJ O
in IN IN O
bed NN NN O
HEENT NNP NNP O
. . . O
- : : O
MMMLungs NNP NNP O
- : : O
clear JJ JJ O
CV NNP NNP O
. . . O
- : : O
tachy NN NN O
but CC CC O
regular JJ JJ O
, , , O
no DT DT O
murmurs NNS NNS O
Abdomen NNP NNP O
. . . O
- : : O
soft JJ JJ O
, , , O
non-distended JJ JJ O
, , , O
reports NNS NNS O
some DT DT O
tenderness NN NN O
to TO TO O
palpation NN NN O
of IN IN O
RLQ NNP NNP O
Ext NNP NNP O
. . . O
- : : O
no DT DT O
edema NN NN O
, , , O
no DT DT O
rash NN NN O
, , , O
w/w/p NN NN O
EKG NNP NNP O
. . . O
Rate NNP NNP O
100 CD CD O
, , , O
sinus JJ JJ O
rhythm NN NN O
, , , O
normal JJ JJ O
axis NNS NNS O
. . . O
No DT DT O
. . . O
acute JJ JJ O
ST NNP NNP O
changes NNS NNS O
, , , O
Q NNP NNP O
waves NNS NNS O
or CC CC O
T NN NN O
wave NN NN O
inversion NN NN O
. . . O
T NN NN O
. . . O
wave NN NN O
flattening NN NN O
in IN IN O
lead NN NN O
II NNP NNP O
. . . O
No DT DT O
. . . O
significant JJ JJ O
change NN NN O
compared VBN VBN O
to TO TO O
prior RB RB O
( ( ( O
2/2080 CD CD I-DATE
) ) ) O
. . . O
Urine NNP NNP O
. . . O
dipstick NN NN O
- : : O
large JJ JJ O
WBCs NNP NNP O
, , , O
large JJ JJ O
RBCs NNP NNP O
FSBG NNP NNP O
. . . O
143 CD CD O
Motrin NNP NNP O
. . . O
X1 NNP NNP O
at IN IN O
triage NN NN O
A/P NNP NNP O
. . . O
70 CD CD I-AGE
y/o NN NN O
woman NN NN O
with IN IN O
PMH NNP NNP O
DM NNP NNP O
, , , O
HTN NNP NNP O
, , , O
high JJ JJ O
cholesterol NN NN O
who WP WP O
was VBD VBD O
recently RB RB O
admitted VBN VBN O
to TO TO O
CMC NNP NNP I-HOSPITAL
ED NNP NNP O
obs NN NN O
unit NN NN O
( ( ( O
last JJ JJ O
week NN NN O
) ) ) O
for IN IN O
back RB RB O
pain NN NN O
now RB RB O
with IN IN O
documented VBN VBN O
high JJ JJ O
fevers NNS NNS O
. . . O
- - - O
. . . O
Blood NNP NNP O
cultures NNS NNS O
( ( ( O
one CD CD O
set VBN VBN O
) ) ) O
with IN IN O
IV NNP NNP O
start NN NN O
, , , O
500cc CD CD O
NS NNP NNP O
bolus JJ JJ O
- - - O
. . . O
Urine NNP NNP O
culture NN NN O
sent VBD VBD O
- : : O
. . . O
Transfer NNP NNP O
to TO TO O
CMC NNP NNP I-HOSPITAL
ER NNP NNP O
for IN IN O
further JJ JJ O
work-up JJ JJ O
, , , O
likely JJ JJ O
admission NN NN O
; : : O
referral JJ JJ O
. . . O
called VBN VBN O
to TO TO O
ED NNP NNP O
access NN NN O
nurse NN NN O
Guadalupe NNP NNP I-DOCTOR
. . . O
Logan NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
, , , O
PGY3 NNP NNP O
CC NNP NNP O
. . . O
: : : O
Dr NNP NNP O
. . . O
Xue NNP NNP "I-   "
. . . O
Personally RB RB O
. . . O
discussed VBD VBD O
differential JJ JJ O
diagnosis NN NN O
and CC CC O
treatment NN NN O
plan NN NN O
with IN IN O
patient NN NN O
. . . O
Pt NNP NNP O
. . . O
agrees NNS NNS O
and CC CC O
demonstrated VBN VBN O
full JJ JJ O
understanding NN NN O
of IN IN O
recommendations NNS NNS O
before IN IN O
discharge NN NN O
. . . O
Discharge NNP NNP O
. . . O
Time NNP NNP O
: : : O
8:30PM CD CD O
   
Record NNP NNP O
date NN NN O
: : : O
2080-06-13 JJ JJ I-DATE
INFECTIOUS NNP NNP O
. . . O
DISEASE NNP NNP O
ASSOCIATES NNP NNP O
CURTIS NNP NNP I-HOSPITAL
. . . O
MEDICAL NNP NNP I-HOSPITAL
CENTER NNP NNP I-HOSPITAL
Reason NNP NNP O
. . . O
for IN IN O
visit NN NN O
Brucellosis NNP NNP O
. . . O
History NN NN O
. . . O
of IN IN O
present JJ JJ O
illness NN NN O
Ms NNP NNP O
. . . O
Iles NNP NNP I-PATIENT
. . . O
is VBZ VBZ O
seen VBN VBN O
here RB RB O
two CD CD O
weeks NNS NNS O
after IN IN O
her PRP$ PRP$ O
discharge NN NN O
from IN IN O
the DT DT O
hospital NN NN O
. . . O
She PRP PRP O
. . . O
has VBZ VBZ O
been VBN VBN O
treated VBN VBN O
for IN IN O
systemic JJ JJ O
brucellosis NN NN O
with IN IN O
suspicion NN NN O
of IN IN O
osteoarticular JJ JJ O
disease NN NN O
given VBN VBN O
her PRP$ PRP$ O
low JJ JJ O
back RB RB O
pain NN NN O
. . . O
She PRP PRP O
. . . O
is VBZ VBZ O
taking VBG VBG O
rifampin NN NN O
, , , O
doxycycline NN NN O
and CC CC O
has VBZ VBZ O
been VBN VBN O
treated VBN VBN O
with IN IN O
streptomycin NN NN O
. . . O
She PRP PRP O
. . . O
feels VBZ VBZ O
quite RB RB O
a DT DT O
bit NN NN O
better JJR JJR O
and CC CC O
has VBZ VBZ O
had VBN VBN O
resolution NN NN O
of IN IN O
her PRP$ PRP$ O
fevers NNS NNS O
and CC CC O
chills NNS NNS O
. . . O
She PRP PRP O
. . . O
has VBZ VBZ O
diminished VBN VBN O
pain NN NN O
and CC CC O
is VBZ VBZ O
able JJ JJ O
to TO TO O
ambulate VB VB O
somewhat RB RB O
and CC CC O
goes VBZ VBZ O
to TO TO O
the DT DT O
bathroom NN NN O
more RBR RBR O
comfortably RB RB O
. . . O
She PRP PRP O
. . . O
still RB RB O
has VBZ VBZ O
weakness NN NN O
and CC CC O
a DT DT O
poor JJ JJ O
appetite NN NN O
. . . O
There EX EX O
. . . O
have VBP VBP O
been VBN VBN O
no DT DT O
change NN NN O
in IN IN O
her PRP$ PRP$ O
bowel NN NN O
habits NNS NNS O
and CC CC O
no DT DT O
fevers NNS NNS O
, , , O
chills NNS NNS O
or CC CC O
rash NN NN O
. . . O
Past JJ JJ O
. . . O
medical JJ JJ O
history NN NN O
- : : O
DMII NNP NNP O
( ( ( O
dx NN NN O
late JJ JJ O
60s NN NN I-DATE
, , , O
last JJ JJ O
A1c NNP NNP O
= SYM SYM O
5.6 CD CD O
in IN IN O
2/80 CD CD I-DATE
) ) ) O
- : : O
. . . O
HTN NNP NNP O
- : : O
. . . O
Hyperlipidemia NNP NNP O
- : : O
. . . O
Hep NNP NNP O
B NNP NNP O
sAb NN NN O
+ NN NN O
, , , O
sAg NN NN O
+ NN NN O
, , , O
and CC CC O
core NN NN O
Ab NNP NNP O
+ NN NN O
in IN IN O
2067 CD CD I-DATE
; : : O
now RB RB O
. . . O
sAg JJ JJ O
- - - O
, , , O
sAb NN NN O
+ NN NN O
, , , O
and CC CC O
core NN NN O
Ab NNP NNP O
(+) NN NN O
in IN IN O
2/2080 CD CD I-DATE
( ( ( O
recovery NN NN O
) ) ) O
- : : O
. . . O
H/o NNP NNP O
H. NN NN O
pylori NN NN O
(+) NN NN O
2068 CD CD I-DATE
and CC CC O
2080 CD CD I-DATE
s/p NN NN O
triple NN NN O
therapy NN NN O
- : : O
. . . O
GERD NNP NNP O
- : : O
. . . O
OA NNP NNP O
- : : O
. . . O
H/o NNP NNP O
vitamin NN NN O
D NNP NNP O
deficiency NN NN O
- : : O
. . . O
H/o NNP NNP O
chronic NN NN O
HAs VBZ VBZ O
( ( ( O
migraines NNS NNS O
vs NNS NNS O
. . . O
tension NN NN O
HAs VBZ VBZ O
) ) ) O
-+ CD CD O
. . . O
PPD NNP NNP O
( ( ( O
in IN IN O
Mississippi NNP NNP I-STATE
in IN IN O
2067 CD CD I-DATE
) ) ) O
- : : O
. . . O
H/o NNP NNP O
malaria NN NN O
Active JJ JJ O
. . . O
Medications NNP NNP O
multivitamins NNS NNS O
. . . O
liquid JJ JJ O
; : : O
Dir NNP NNP O
. . . O
: : : O
One CD CD O
teaspoon NN NN O
daily JJ JJ O
metformin NN NN O
. . . O
hydrochloride NN NN O
500 CD CD O
MG NNP NNP O
PO NNP NNP O
BID NNP NNP O
lisinopril NN NN O
. . . O
20 CD CD O
MG NNP NNP O
PO NNP NNP O
daily JJ JJ O
atenolol NN NN O
. . . O
50 CD CD O
MG NNP NNP O
PO NNP NNP O
daily JJ JJ O
Zofran NNP NNP O
. . . O
4 CD CD O
MG NNP NNP O
PO NNP NNP O
Q8H NNP NNP O
aspirin NN NN O
. . . O
81 CD CD O
MG NNP NNP O
PO NNP NNP O
daily JJ JJ O
morphine NN NN O
. . . O
sulfate NN NN O
immediate JJ JJ O
release NN NN O
PO NNP NNP O
Q4H NNP NNP O
PRN NNP NNP O
Ms NNP NNP O
. . . O
contin NN NN O
PO NNP NNP O
Q12H NNP NNP O
simvastatin NN NN O
. . . O
40 CD CD O
MG NNP NNP O
PO NNP NNP O
QPM NNP NNP O
Review NNP NNP O
. . . O
of IN IN O
systems NNS NNS O
Denies NNP NNP O
fever NN NN O
, , , O
rigor NN NN O
, , , O
night NN NN O
sweats NNS NNS O
, , , O
headache NN NN O
, , , O
SOB NNP NNP O
, , , O
cough NN NN O
, , , O
anorexia NN NN O
, , , O
nausea NN NN O
, , , O
vomiting VBG VBG O
, , , O
diarrhea NN NN O
, , , O
abdominal JJ JJ O
pain NN NN O
, , , O
paresthesias NN NN O
, , , O
or CC CC O
rash NN NN O
. . . O
Physical JJ JJ O
. . . O
Exam NNP NNP O
Pulse NNP NNP O
. . . O
120 CD CD O
Blood NNP NNP O
. . . O
pressure NN NN O
160/70 CD CD O
respiratory NN NN O
. . . O
rate NN NN O
16 CD CD O
weight NN NN O
. . . O
181 CD CD O
lbs NN NN O
. . . O
, , , O
. . . O
temperature NN NN O
98.6 CD CD O
. . . O
General NNP NNP O
. . . O
appearance NN NN O
Well RB RB O
appearing VBG VBG O
. . . O
Skin NNP NNP O
. . . O
No DT DT O
rash NN NN O
or CC CC O
jaundice NN NN O
. . . O
HEENT NNP NNP O
. . . O
No DT DT O
thrush NN NN O
. . . O
Nodes NNS NNS O
. . . O
None NN NN O
. . . O
Chest NN NN O
. . . O
Clear NNP NNP O
. . . O
Cor NNP NNP O
. . . O
Normal NNP NNP O
PMI NNP NNP O
. . . O
Regular NNP NNP O
. . . O
rate NN NN O
and CC CC O
rhythm NN NN O
, , , O
1/6 CD CD O
systolic JJ JJ O
ejection NN NN O
murmur NN NN O
is VBZ VBZ O
unchanged JJ JJ O
. . . O
No DT DT O
. . . O
rub NN NN O
, , , O
gallop NN NN O
or CC CC O
click NN NN O
. . . O
Abdomen NNP NNP O
. . . O
Soft JJ JJ O
without IN IN O
hepatosplenomegaly NN NN O
, , , O
mass NN NN O
or CC CC O
ascites NNS NNS O
. . . O
Musc NNP NNP O
. . . O
skel NN NN O
There EX EX O
is VBZ VBZ O
some DT DT O
persistent JJ JJ O
tenderness NN NN O
in IN IN O
the DT DT O
left JJ JJ O
sacroiliac NN NN O
region NN NN O
in IN IN O
her PRP$ PRP$ O
lower JJR JJR O
back RB RB O
. . . O
Selected NNP NNP O
. . . O
recent JJ JJ O
labs NNS NNS O
Include NNP NNP O
, , , O
sodium NN NN O
134 CD CD O
, , , O
creatinine NN NN O
0.6 CD CD O
, , , O
glucose NN NN O
147 CD CD O
, , , O
calcium NN NN O
9.0 CD CD O
. . . O
SGOT NNP NNP O
. . . O
86 CD CD O
, , , O
SGPT NNP NNP O
75 CD CD O
and CC CC O
these DT DT O
are VBP VBP O
both DT DT O
lower JJR JJR O
than IN IN O
in IN IN O
the DT DT O
hospital NN NN O
. . . O
Iron NNP NNP O
. . . O
31 CD CD O
, , , O
TIBC NNP NNP O
164 CD CD O
. . . O
Hematocrit NNP NNP O
. . . O
37 CD CD O
, , , O
white JJ JJ O
blood NN NN O
cell NN NN O
count NN NN O
4 CD CD O
, , , O
platelets NNS NNS O
411,000 CD CD O
. . . O
Followup NNP NNP O
. . . O
blood NN NN O
cultures NNS NNS O
drawn VBN VBN O
in IN IN O
the DT DT O
hospital NN NN O
, , , O
sterilized VBN VBN O
on IN IN O
therapy NN NN O
. . . O
Assessment NNP NNP O
. . . O
and CC CC O
plan NN NN O
. . . O
Continue NNP NNP O
. . . O
with IN IN O
doxycycline NN NN O
and CC CC O
rifampin NN NN O
for IN IN O
brucellosis NNS NNS O
. . . O
Follow VB VB O
. . . O
up RP RP O
with IN IN O
Dr NNP NNP O
. . . O
Tillman NNP NNP I-DOCTOR
. . . O
skin NN NN O
in IN IN O
one CD CD O
month NN NN O
. . . O
Liver NNP NNP O
. . . O
function NN NN O
test NN NN O
and CC CC O
CBC NNP NNP O
drawn VBP VBP O
today NN NN O
. . . O
Low NNP NNP O
. . . O
suspicion NN NN O
of IN IN O
endocarditis NNS NNS O
. . . O
We PRP PRP O
. . . O
anticipate VBP VBP O
therapy NN NN O
to TO TO O
be VB VB O
six CD CD O
months NNS NNS O
. . . O
FOLLOWUP NNP NNP O
. . . O
: : : O
One CD CD O
month NN NN O
. . . O
Todd NNP NNP I-DOCTOR
. . . O
Riley NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Signed NNP NNP O
. . . O
electronically RB RB O
by IN IN O
Todd NNP NNP I-DOCTOR
Riley NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Document NNP NNP O
. . . O
Status NNP NNP O
: : : O
Final NNP NNP O
   
Record NNP NNP O
date NN NN O
: : : O
2080-03-13 JJ JJ I-DATE
Ms NNP NNP O
. . . O
. . . O
Louise NNP NNP I-PATIENT
. . . O
Iles NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
70 CD CD I-AGE
year NN NN O
old JJ JJ O
female JJ JJ O
patient NN NN O
of IN IN O
Dr NNP NNP O
. . . O
Xue NNP NNP I-DOCTOR
. . . O
here RB RB O
today NN NN O
with IN IN O
first JJ JJ O
visit NN NN O
with IN IN O
me PRP PRP O
for IN IN O
several JJ JJ O
issues NNS NNS O
. . . O
Met NNP NNP O
. . . O
with IN IN O
PCP NNP NNP O
in IN IN O
Feb NNP NNP I-DATE
for IN IN O
multiple JJ JJ O
issues NNS NNS O
, , , O
DM NNP NNP O
changed VBD VBD O
from IN IN O
Actos NNP NNP O
to TO TO O
Metformin NNP NNP O
, , , O
referral NN NN O
to TO TO O
Internal NNP NNP O
Medicine NNP NNP O
; : : O
GERD/H-pylori NNP NNP O
. . . O
, , , O
( ( ( O
on IN IN O
meds NNS NNS O
, , , O
GI NNP NNP O
consult NN NN O
) ) ) O
HTN NNP NNP O
( ( ( O
changed VBN VBN O
from IN IN O
nitrates NNS NNS O
to TO TO O
Lisinopril NNP NNP O
) ) ) O
cholesterol NN NN O
, , , O
HA NNP NNP O
( ( ( O
lab NN NN O
done VBN VBN O
to TO TO O
r/o VB VB O
TA NNP NNP O
and CC CC O
PMR NNP NNP O
) ) ) O
Hepatitis NNP NNP O
She PRP PRP O
. . . O
arrived VBD VBD O
20 CD CD O
minutes NNS NNS O
late RB RB O
for IN IN O
her PRP$ PRP$ O
appointment NN NN O
Today NNP NNP O
. . . O
states NNS NNS O
: : : O
# # # O
. . . O
1 CD CD O
HA NNP NNP O
HA NNP NNP O
. . . O
are VBP VBP O
much RB RB O
better-less JJ JJ O
in IN IN O
frequency NN NN O
and CC CC O
duration NN NN O
and CC CC O
intensity NN NN O
, , , O
Left NNP NNP O
area NN NN O
occipital/temporal JJ JJ O
area NN NN O
ROS NNP NNP O
. . . O
denies NNS NNS O
any DT DT O
visual JJ JJ O
problems-but JJ JJ O
does VBZ VBZ O
associate VB VB O
them PRP PRP O
with IN IN O
stressful JJ JJ O
times NNS NNS O
# # # O
. . . O
2 CD CD O
DM NNP NNP O
Test NNP NNP O
. . . O
her PRP$ PRP$ O
BG NNP NNP O
once RB RB O
a DT DT O
week-reports JJ JJ O
134 CD CD O
, , , O
today NN NN O
156-ate JJ JJ O
at IN IN O
1 CD CD O
PM NNP NNP O
rice NN NN O
Stopped NNP NNP O
. . . O
Actos-now NNP NNP O
taking VBG VBG O
Metformin NNP NNP O
# # # O
. . . O
3 CD CD O
HTN NNP NNP O
taking VBG VBG O
. . . O
meds NNS NNS O
as IN IN O
prescribed VBN VBN O
# # # O
. . . O
4 CD CD O
GERD NNP NNP O
: : : O
completed VBN VBN O
antibiotics-feeling JJ JJ O
better JJR JJR O
Medications NNP NNP O
. . . O
Amoxicillin NNP NNP O
. . . O
1000 CD CD O
MG NNP NNP O
( ( ( O
500 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take VB VB O
2 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
x SYM SYM O
14 CD CD O
days NNS NNS O
#56 NN NN O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
Aspirin NNP NNP O
. . . O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
) ) ) O
81 CD CD O
MG NNP NNP O
( ( ( O
81 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take VB VB O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#30 NN NN O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
Atenolol NNP NNP O
. . . O
50 CD CD O
MG NNP NNP O
( ( ( O
50MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#30 NN NN O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
Ergocalciferol NNP NNP O
. . . O
50000 CD CD O
UNITS NNP NNP O
( ( ( O
50000 CD CD O
UNIT NNP NNP O
CAPSULE NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QWEEK NNP NNP O
x SYM SYM O
42 CD CD O
days NNS NNS O
#6 NN NN O
Capsule NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
Lipitor NNP NNP O
. . . O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
40 CD CD O
MG NNP NNP O
( ( ( O
40 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take VB VB O
1 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#30 NN NN O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
Lisinopril NNP NNP O
. . . O
5 CD CD O
MG NNP NNP O
( ( ( O
5 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take VB VB O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#30 NN NN O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
Metformin NNP NNP O
. . . O
500 CD CD O
MG NNP NNP O
( ( ( O
500 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take VB VB O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#60 NN NN O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
Omeprazole NNP NNP O
. . . O
20 CD CD O
MG NNP NNP O
( ( ( O
20 CD CD O
MG NNP NNP O
TABLET NNP NNP O
DR NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
x SYM SYM O
14 CD CD O
days NNS NNS O
#28 NN NN O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
Problems NNS NNS O
. . . O
Diabetes NNP NNP O
. . . O
mellitus NN NN O
: : : O
dx NN NN O
late JJ JJ O
2060s CD CD I-DATE
. . . O
No DT DT O
. . . O
h/o NN NN O
macro NN NN O
or CC CC O
microvascular NN NN O
complications NNS NNS O
. . . O
Hypertensive NNP NNP O
. . . O
disorder NN NN O
: : : O
dx NN NN O
2060s NN NN I-DATE
, , , O
was VBD VBD O
taking VBG VBG O
atenolol NN NN O
, , , O
enalapril NN NN O
and CC CC O
isosorbide NN NN O
in IN IN O
UNITED NNP NNP I-COUNTRY
KINGDOM NNP NNP I-COUNTRY
Hypercholesterolemia NNP NNP O
. . . O
Obesity NNP NNP O
. . . O
Osteoarthritis NNP NNP O
. . . O
: : : O
L NNP NNP O
knee NN NN O
worst JJS JJS O
spot NN NN O
Gastroesophageal NNP NNP O
. . . O
reflux NN NN O
disease NN NN O
: : : O
x SYM SYM O
years NNS NNS O
, , , O
never RB RB O
had VBD VBD O
EGD NNP NNP O
. . . O
H. NN NN O
. . . O
pylori NN NN O
serology NN NN O
+ NN NN O
Helicobacter NNP NNP O
. . . O
pylori NN NN O
: : : O
serology NN NN O
positive JJ JJ O
2068 CD CD I-DATE
and CC CC O
re-check NN NN O
2/2080 CD CD I-DATE
, , , O
no DT DT O
Ag NNP NNP O
done VBN VBN O
. . . O
Given VBN VBN O
. . . O
triple NN NN O
therapy NN NN O
Rx NNP NNP O
by IN IN O
Internal NNP NNP O
Medicine NNP NNP O
Vitamin NNP NNP O
. . . O
D NNP NNP O
deficiency NN NN O
Hepatitis NNP NNP O
. . . O
B NNP NNP O
antibody NN NN O
present JJ JJ O
: : : O
Had VBD VBD O
HbsAg NNP NNP O
+ NN NN O
and CC CC O
HbsAb NNP NNP O
+ NN NN O
in IN IN O
2067 CD CD I-DATE
. . . O
LFTs NNP NNP O
. . . O
wnl NN NN O
2067 CD CD I-DATE
and CC CC O
2080 CD CD I-DATE
. . . O
Allergies NNP NNP O
. . . O
NKA NNP NNP O
. . . O
O NNP NNP O
. . . O
: : : O
Vital NNP NNP O
. . . O
Signs NNP NNP O
BP NNP NNP O
. . . O
160/80 CD CD O
, , , O
Wt NNP NNP O
203.8 CD CD O
lb NN NN O
Neck NNP NNP O
. . . O
: : : O
no DT DT O
bruits NNS NNS O
Cardiac NNP NNP O
. . . O
: : : O
HR NNP NNP O
76 CD CD O
RRR NNP NNP O
, , , O
no DT DT O
murmurs NNS NNS O
rubs NNS NNS O
or CC CC O
gallops NNS NNS O
BP NNP NNP O
. . . O
both DT DT O
arms NNS NNS O
162/80 CD CD O
FINGER NNP NNP O
. . . O
BLOOD NNP NNP O
GLUCOSE NNP NNP O
156 CD CD O
two CD CD O
hours NNS NNS O
PP NNP NNP O
PAIN NN NN O
. . . O
LEVEL NNP NNP O
( ( ( O
0-10 NN NN O
) ) ) O
0 CD CD O
general JJ JJ O
. . . O
: : : O
overweight NN NN O
female NN NN O
in IN IN O
NAD NNP NNP O
Pneumo NNP NNP O
. . . O
vaccine NN NN O
: : : O
. . . O
5 CD CD O
. . . O
ml NN NN O
given VBN VBN O
in IN IN O
right NN NN O
deltoid NN NN O
without IN IN O
difficulty NN NN O
Tdap NNP NNP O
. . . O
. . . O
5 CD CD O
. . . O
ml NN NN O
given VBN VBN O
in IN IN O
left VBN VBN O
deltoid NN NN O
without IN IN O
difficulty NN NN O
Results02/15/2080 NNP NNP O
. . . O
CHOL NNP NNP O
187 CD CD O
[ NN NN O
1 CD CD O
] NN NN O
, , , O
TRIG NNP NNP O
137 CD CD O
, , , O
HDL NNP NNP O
37 CD CD O
, , , O
LDL NNP NNP O
123 CD CD O
[ NN NN O
2 CD CD O
] NN NN O
, , , O
CHOL/HDL NNP NNP O
5.1 CD CD O
[3][1] NN NN O
RESULT NNP NNP O
COMMENT NNP NNP O
: : : O
DESIRABLE NNP NNP O
: : : O
& CC CC O
lt NN NN O
; : : O
200[2 CD CD O
. . . O
] NN NN O
RESULT NNP NNP O
COMMENT NNP NNP O
: : : O
DESIRABLE NNP NNP O
: : : O
& CC CC O
lt NN NN O
; : : O
130[3 CD CD O
. . . O
] NN NN O
RESULT NNP NNP O
COMMENT NNP NNP O
: : : O
NORMAL JJ JJ O
RISK NNP NNP O
RATIO NN NN O
: : : O
5.0 CD CD O
OR CC CC O
LESS02/15/2080 NNP NNP O
UCREAT NNP NNP O
1.39 CD CD O
, , , O
MALB NNP NNP O
2.2 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
MALB/CRE NNP NNP O
15.802/15/2080 CD CD O
WBC NNP NNP O
4.2 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
RBC NNP NNP O
4.21 CD CD O
, , , O
HGB NNP NNP O
13.1 CD CD O
, , , O
HCT NNP NNP O
39.9 CD CD O
, , , O
MCV NNP NNP O
95 CD CD O
, , , O
MCH NNP NNP O
31.0 CD CD O
, , , O
MCHC NNP NNP O
32.7 CD CD O
, , , O
PLT NNP NNP O
22502/15/2080 CD CD O
RDW NNP NNP O
13.602/15/2080 CD CD O
METHOD NNP NNP O
Auto NNP NNP O
, , , O
% NN NN O
NEUT NNP NNP O
40 CD CD O
, , , O
% NN NN O
LYMPH NNP NNP O
52 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
% NN NN O
MONO NNP NNP O
6 CD CD O
, , , O
% NN NN O
EOS NNP NNP O
1 CD CD O
, , , O
% NN NN O
BASO NNP NNP O
102/15/2080 CD CD O
ESR NNP NNP O
21 CD CD O
(H)02/15/2080 NN NN O
HBV-CAB NNP NNP O
Positive NNP NNP O
[ NN NN O
1 CD CD O
] NN NN O
, , , O
HBV-SAB NNP NNP O
Reactive NNP NNP O
, , , O
HBV-SAG NNP NNP O
Negative[1] NNP NNP O
RESULT NNP NNP O
COMMENT NNP NNP O
: : : O
Reference NN NN O
range NN NN O
: : : O
Negative(NOTE)If NNP NNP O
clinically RB RB O
indicated VBD VBD O
, , , O
testing NN NN O
for IN IN O
Hepatitis NNP NNP O
B NNP NNP O
Core NNP NNP O
IgMAntibody NNP NNP O
, , , O
Serum NNP NNP O
, , , O
is VBZ VBZ O
necessary JJ JJ O
to TO TO O
confirm VB VB O
an DT DT O
acute JJ JJ O
or CC CC O
recentinfection.Performed VBN VBN O
by IN IN O
HMH NNP NNP I-ORGANIZATION
LABORATORIES NNP NNP I-ORGANIZATION
, , , O
382 CD CD I-STREET
Farmington NNP NNP I-STREET
Road,Mount NNP NNP O
Morris NNP NNP I-CITY
, , , O
AK NNP NNP I-STATE
34712RadiologyExam CD CD O
Number NNP NNP O
: : : O
13929520 CD CD I-MEDICALRECORD
Report NNP NNP O
Status NNP NNP O
: : : O
FinalType NNP NNP O
: : : O
Chest NN NN O
2 CD CD O
ViewsDate/Time NNP NNP O
: : : O
02/15/2080 CD CD I-DATE
09:04Exam CD CD O
Code NNP NNP O
: : : O
DNSW2Ordering NNP NNP O
Provider NNP NNP O
: : : O
Xue NNP NNP I-DOCTOR
, , , I-DOCTOR
Laura NNP NNP I-DOCTOR
M.D.REPORT NNP NNP O
Frontal NNP NNP O
and CC CC O
lateral NN NN O
views NNS NNS O
of IN IN O
the DT DT O
chest NN NN O
. . . O
COMPARISON NNP NNP O
. . . O
: : : O
None NN NN O
FINDINGS NNS NNS O
: : : O
Lines/tubes NNP NNP O
: : : O
None NN NN O
. . . O
Lungs NNP NNP O
. . . O
: : : O
Bandlike NNP NNP O
opacity NN NN O
consistent JJ JJ O
with IN IN O
subsegmental JJ JJ O
plate NN NN O
atelectasis NN NN O
at IN IN O
the DT DT O
left VBN VBN O
lung NN NN O
base NN NN O
. . . O
Otherwise RB RB O
. . . O
clear JJ JJ O
lungs NNS NNS O
. . . O
Pleura NNP NNP O
. . . O
: : : O
There EX EX O
is VBZ VBZ O
no DT DT O
pleural JJ JJ O
effusion NN NN O
or CC CC O
pneumothorax NN NN O
. . . O
Heart NNP NNP O
. . . O
and CC CC O
mediastinum NN NN O
: : : O
The DT DT O
heart NN NN O
and CC CC O
the DT DT O
mediastinum NN NN O
are VBP VBP O
normal JJ JJ O
. . . O
Bones NNP NNP O
. . . O
: : : O
The DT DT O
thoracic NN NN O
skeleton NN NN O
is VBZ VBZ O
unremarkable JJ JJ O
. . . O
IMPRESSION NNP NNP O
. . . O
: : : O
Bandlike NNP NNP O
opacity NN NN O
consistent JJ JJ O
with IN IN O
subsegmental JJ JJ O
plate NN NN O
atelectasis NN NN O
at IN IN O
the DT DT O
left VBN VBN O
lung NN NN O
base NN NN O
. . . O
Otherwise RB RB O
. . . O
clear JJ JJ O
lungs NNS NNS O
. . . O
RADIOLOGISTS NNP NNP O
. . . O
: : : O
SIGNATURES NNP NNP O
: : : O
Querry NNP NNP I-DOCTOR
, , , I-DOCTOR
Lucas NNP NNP I-DOCTOR
Edwin NNP NNP I-DOCTOR
MD NNP NNP O
Querry NNP NNP I-DOCTOR
, , , I-DOCTOR
Lucas NNP NNP I-DOCTOR
Edwin NNP NNP I-DOCTOR
MD NNP NNP O
A DT DT O
. . . O
: : : O
# # # O
1 CD CD O
HA NNP NNP O
: : : O
better JJR JJR O
sounds VBZ VBZ O
more RBR RBR O
like IN IN O
stress-reviewed JJ JJ O
deep JJ JJ O
breathing NN NN O
and CC CC O
monitoring NN NN O
# # # O
. . . O
2 CD CD O
DM NNP NNP O
last JJ JJ O
A1C NNP NNP O
excellent NN NN O
at IN IN O
5.9 CD CD O
% NN NN O
Eye NNP NNP O
. . . O
: : : O
seen VBN VBN O
by IN IN O
Internal NNP NNP O
Medicine-needs NNP NNP O
repeat NN NN O
in IN IN O
1-2 JJ JJ O
months NNS NNS O
for IN IN O
inadequate JJ JJ O
image NN NN O
of IN IN O
right JJ JJ O
eye NN NN O
Feet NNS NNS O
. . . O
: : : O
address NN NN O
next JJ JJ O
visit NN NN O
lipids NNS NNS O
. . . O
: : : O
LDL NNP NNP O
123-but NN NN O
HAV NNP NNP O
+ NN NN O
discussed VBD VBD O
with IN IN O
PCP NNP NNP O
before IN IN O
beginning VBG VBG O
meds NNS NNS O
ASA NNP NNP O
. . . O
81 CD CD O
mg NN NN O
daily JJ JJ O
Microalbumin NNP NNP O
. . . O
: : : O
2.2-just JJ JJ O
began VBD VBD O
Lisinopril NNP NNP O
last JJ JJ O
month NN NN O
# # # O
. . . O
3 CD CD O
HTN NNP NNP O
: : : O
above IN IN O
target NN NN O
today NN NN O
increase NN NN O
Lisinopril NNP NNP O
to TO TO O
10 CD CD O
mg NN NN O
# # # O
. . . O
4 CD CD O
GERD-better NNP NNP O
after IN IN O
treatment-schedule JJ JJ O
to TO TO O
see VB VB O
GI NN NN O
# # # O
. . . O
5 CD CD O
Low NNP NNP O
WBC NNP NNP O
3.4 CD CD O
in IN IN O
2/80 CD CD I-DATE
then RB RB O
up IN IN O
to TO TO O
4.2 CD CD O
in IN IN O
feb NNP NNP I-DATE
# # # O
. . . O
6 CD CD O
Low NNP NNP O
Vitamin NNP NNP O
D-taking NNP NNP O
replacement NN NN O
PPD NNP NNP O
. . . O
per IN IN O
patient NN NN O
+ NN NN O
in IN IN O
Mississippi-did NNP NNP O
not RB RB O
plant NN NN O
given VBN VBN O
. . . O
verbal JJ JJ O
consent NN NN O
to TO TO O
administer VB VB O
Pneumo NNP NNP O
vaccine NN NN O
and CC CC O
Tdap-declined NNP NNP O
H NNP NNP O
1 CD CD O
N NNP NNP O
1 CD CD O
and CC CC O
flu NN NN O
P NN NN O
. . . O
: : : O
PPD NNP NNP O
, , , O
tdap NN NN O
, , , O
H NNP NNP O
1 CD CD O
N NNP NNP O
1 CD CD O
, , , O
Pneumo NNP NNP O
vaccine NN NN O
Lisinopril NNP NNP O
. . . O
10 CD CD O
mg NN NN O
po NN NN O
daily-recheck NN NN O
BMP NNP NNP O
in IN IN O
6 CD CD O
weeks NNS NNS O
screening VBG VBG O
. . . O
mammogram NN NN O
and CC CC O
Bone NNP NNP O
density NN NN O
Given VBN VBN O
. . . O
medication NN NN O
list NN NN O
to TO TO O
compare VB VB O
home NN NN O
bottles NNS NNS O
RTC NNP NNP O
. . . O
: : : O
In IN IN O
2 CD CD O
weeks NNS NNS O
for IN IN O
BP NNP NNP O
check NN NN O
April NNP NNP I-DATE
with IN IN O
PCP NNP NNP O
and CC CC O
two CD CD O
months NNS NNS O
with IN IN O
me PRP PRP O
for IN IN O
shared VBN VBN O
care NN NN O
RCHM NNP NNP O
. . . O
: : : O
PE NNP NNP O
( ( ( O
2/80 CD CD I-DATE
) ) ) O
PAP NNP NNP O
none NN NN O
in IN IN O
LMR NNP NNP O
needs VBZ VBZ O
: : : O
immunizations NNS NNS O
: : : O
pneumo NN NN O
vaccine NN NN O
and CC CC O
Tdap NNP NNP O
Visit NNP NNP O
. . . O
lasted VBD VBD O
45 CD CD O
minutes NNS NNS O
& CC CC O
gt NN NN O
; : : O
50 CD CD O
. . . O
% NN NN O
of IN IN O
time NN NN O
spent VBD VBD O
on IN IN O
medications NNS NNS O
, , , O
BG NNP NNP O
, , , O
vaccine NN NN O
and CC CC O
up RP RP O
coming VBG VBG O
appointment NN NN O
Entire JJ JJ O
. . . O
visit NN NN O
done VBN VBN O
with IN IN O
professional JJ JJ O
staff NN NN O
interpreter NN NN O
. . . O
Medication NNP NNP O
. . . O
and CC CC O
allergies NNS NNS O
reviewed VBN VBN O
and CC CC O
reconciled VBN VBN O
with IN IN O
patient NN NN O
   
Record NNP NNP O
date NN NN O
: : : O
2081-01-04 JJ JJ I-DATE
INFECTIOUS NNP NNP O
. . . O
DISEASE NNP NNP O
ASSOCIATES NNP NNP O
CURTIS NNP NNP I-HOSPITAL
. . . O
MEDICAL NNP NNP I-HOSPITAL
CENTER NNP NNP I-HOSPITAL
Reason NNP NNP O
. . . O
for IN IN O
visit NN NN O
Brucellosis NNP NNP O
History NN NN O
. . . O
of IN IN O
present JJ JJ O
illness NN NN O
70y/o CD CD O
F NN NN O
who WP WP O
presented VBD VBD O
in IN IN O
late JJ JJ O
May NNP NNP I-DATE
with IN IN O
daily JJ JJ O
fever NN NN O
x SYM SYM O
2-3 JJ JJ O
months NNS NNS O
with IN IN O
low JJ JJ O
back RB RB O
pain NN NN O
x SYM SYM O
2 CD CD O
weeks NNS NNS O
, , , O
admitted VBN VBN O
May NNP NNP I-DATE
30 CD CD I-DATE
and CC CC O
found VBD VBD O
to TO TO O
have VB VB O
small JJ JJ O
gram NN NN O
negative JJ JJ O
rod NN NN O
bacteremia NN NN O
consistent JJ JJ O
with IN IN O
Brucellosis NNP NNP O
, , , O
which WDT WDT O
fits VBZ VBZ O
with IN IN O
her PRP$ PRP$ O
epidemiologic JJ JJ O
exposure NN NN O
to TO TO O
unpasteurized JJ JJ O
camels NNS NNS O
milk NN NN O
and CC CC O
her PRP$ PRP$ O
prolonged JJ JJ O
fever NN NN O
. . . O
There EX EX O
. . . O
was VBD VBD O
initial JJ JJ O
concern NN NN O
for IN IN O
TB NNP NNP O
, , , O
but CC CC O
she PRP PRP O
ruled VBD VBD O
out IN IN O
for IN IN O
pulmonary JJ JJ O
tb NN NN O
with IN IN O
3 CD CD O
negative JJ JJ O
smears NNS NNS O
. . . O
PPD NNP NNP O
. . . O
positive JJ JJ O
. . . O
She PRP PRP O
. . . O
had VBD VBD O
an DT DT O
MRI NNP NNP O
of IN IN O
her PRP$ PRP$ O
spine NN NN O
that WDT WDT O
was VBD VBD O
initially RB RB O
read VBN VBN O
as IN IN O
L5/S1 NNP NNP O
diskitis/osteomyelitis VBD VBD O
with IN IN O
right NN NN O
paraspinal NN NN O
phlegmon NN NN O
. . . O
MSK NNP NNP O
. . . O
radiologists NNS NNS O
felt VBD VBD O
that IN IN O
this DT DT O
actually RB RB O
represented VBN VBN O
degenerative JJ JJ O
change NN NN O
with IN IN O
no DT DT O
evidence NN NN O
of IN IN O
infection NN NN O
, , , O
with IN IN O
explanation NN NN O
that IN IN O
a DT DT O
large JJ JJ O
right-sided JJ JJ O
osteophyte NN NN O
is VBZ VBZ O
causing VBG VBG O
irritation NN NN O
. . . O
Mrs NNP NNP O
. . . O
. . . O
Iles NNP NNP I-PATIENT
. . . O
declined VBD VBD O
a DT DT O
TEE NNP NNP O
on IN IN O
during IN IN O
her PRP$ PRP$ O
admission NN NN O
. . . O
She PRP PRP O
. . . O
was VBD VBD O
treated VBN VBN O
with IN IN O
streptomycin NN NN O
IM NNP NNP O
q NN NN O
daily JJ JJ O
x SYM SYM O
2 CD CD O
weeks,and NN NN O
concurrent NN NN O
doxycycline NN NN O
100 CD CD O
mg NN NN O
po NN NN O
bid NN NN O
plus CC CC O
rifampin NN NN O
300 CD CD O
mg NN NN O
po NN NN O
tid NN NN O
. . . O
She PRP PRP O
. . . O
was VBD VBD O
seen VBN VBN O
in IN IN O
ID NNP NNP O
clinic NN NN O
on IN IN O
7/20 CD CD I-DATE
, , , O
9/7 CD CD I-DATE
, , , O
11/9 CD CD I-DATE
, , , O
and CC CC O
today NN NN O
( ( ( O
1/4/81 CD CD I-DATE
) ) ) O
. . . O
She PRP PRP O
. . . O
has VBZ VBZ O
improved VBN VBN O
dramatically RB RB O
, , , O
and CC CC O
is VBZ VBZ O
able JJ JJ O
to TO TO O
walk VB VB O
independently RB RB O
without IN IN O
pain NN NN O
. . . O
She PRP PRP O
. . . O
has VBZ VBZ O
no DT DT O
fevers NNS NNS O
, , , O
night NN NN O
sweats NNS NNS O
, , , O
weight NN NN O
loss NN NN O
, , , O
nausea NN NN O
, , , O
or CC CC O
vomiting VBG VBG O
. . . O
Her PRP$ PRP$ O
. . . O
pain NN NN O
is VBZ VBZ O
well RB RB O
controlled VBN VBN O
minimal NN NN O
medications NNS NNS O
. . . O
Past JJ JJ O
. . . O
medical JJ JJ O
history NN NN O
- : : O
DMII NNP NNP O
( ( ( O
dx NN NN O
late JJ JJ O
60s NN NN I-DATE
, , , O
last JJ JJ O
A1c NNP NNP O
= SYM SYM O
5.6 CD CD O
in IN IN O
2/80 CD CD I-DATE
) ) ) O
- : : O
. . . O
HTN NNP NNP O
- : : O
. . . O
Hyperlipidemia NNP NNP O
- : : O
. . . O
Hep NNP NNP O
B NNP NNP O
sAb NN NN O
+ NN NN O
, , , O
sAg NN NN O
+ NN NN O
, , , O
and CC CC O
core NN NN O
Ab NNP NNP O
+ NN NN O
in IN IN O
2067 CD CD I-DATE
; : : O
now RB RB O
. . . O
sAg JJ JJ O
- - - O
, , , O
sAb NN NN O
+ NN NN O
, , , O
and CC CC O
core NN NN O
Ab NNP NNP O
(+) NN NN O
in IN IN O
2/2080 CD CD I-DATE
( ( ( O
recovery NN NN O
) ) ) O
- : : O
. . . O
H/o NNP NNP O
H. NN NN O
pylori NN NN O
(+) NN NN O
2068 CD CD I-DATE
and CC CC O
2080 CD CD I-DATE
s/p NN NN O
triple NN NN O
therapy NN NN O
- : : O
. . . O
GERD NNP NNP O
- : : O
. . . O
OA NNP NNP O
- : : O
. . . O
H/o NNP NNP O
vitamin NN NN O
D NNP NNP O
deficiency NN NN O
- : : O
. . . O
H/o NNP NNP O
chronic NN NN O
HAs VBZ VBZ O
( ( ( O
migraines NNS NNS O
vs NNS NNS O
. . . O
tension NN NN O
HAs VBZ VBZ O
) ) ) O
-+ CD CD O
. . . O
PPD NNP NNP O
( ( ( O
in IN IN O
Mississippi NNP NNP I-STATE
in IN IN O
2067 CD CD I-DATE
) ) ) O
- : : O
. . . O
H/o NNP NNP O
malaria NN NN O
Social NNP NNP O
. . . O
history NN NN O
No DT DT O
tobacco NN NN O
, , , O
EtOH NNP NNP O
, , , O
illicits NNS NNS O
. . . O
Currently RB RB O
. . . O
living VBG VBG O
with IN IN O
daughter NN NN O
in IN IN O
Grand NNP NNP I-CITY
Island NNP NNP I-CITY
. . . O
No DT DT O
. . . O
pets NNS NNS O
. . . O
No DT DT O
. . . O
known VBN VBN O
sick JJ JJ O
contacts NNS NNS O
. . . O
Changes NNS NNS O
. . . O
to TO TO O
Allergies NNP NNP O
NKA NNP NNP O
. . . O
: : : O
No DT DT O
Known VBN VBN O
Allergies NNP NNP O
- - - O
reaction NN NN O
: : : O
[ NN NN O
reviewed VBD VBD O
] NN NN O
Review NNP NNP O
. . . O
of IN IN O
systems NNS NNS O
Denies NNP NNP O
fever NN NN O
, , , O
rigor NN NN O
, , , O
night NN NN O
sweats NNS NNS O
, , , O
headache NN NN O
, , , O
SOB NNP NNP O
, , , O
cough NN NN O
, , , O
anorexia NN NN O
, , , O
nausea NN NN O
, , , O
vomiting VBG VBG O
, , , O
diarrhea NN NN O
, , , O
abdominal JJ JJ O
pain NN NN O
, , , O
paresthesias NN NN O
, , , O
or CC CC O
rash NN NN O
. . . O
Physical JJ JJ O
. . . O
Exam NNP NNP O
General NNP NNP O
. . . O
appearance NN NN O
NAD NNP NNP O
Skin NNP NNP O
. . . O
No DT DT O
rashes NNS NNS O
HEENT NNP NNP O
. . . O
No DT DT O
palpable JJ JJ O
LN NNP NNP O
, , , O
no DT DT O
oral JJ JJ O
lesions NNS NNS O
Cor NNP NNP O
. . . O
S1 NNP NNP O
S2 NNP NNP O
, , , O
no DT DT O
murmurs NNS NNS O
, , , O
no DT DT O
peripheral JJ JJ O
stigmata NN NN O
of IN IN O
endocarditis NNS NNS O
Abdomen NNP NNP O
. . . O
Non NNP NNP O
tender NN NN O
, , , O
BS NNP NNP O
+ NN NN O
, , , O
No DT DT O
palpable JJ JJ O
organomegaly NN NN O
Extrem NNP NNP O
. . . O
No DT DT O
clubbing VBG VBG O
, , , O
mild JJ JJ O
edema NN NN O
at IN IN O
the DT DT O
ankles NNS NNS O
Musc NNP NNP O
. . . O
skel NN NN O
No DT DT O
tenderness NN NN O
on IN IN O
the DT DT O
lower JJR JJR O
back RB RB O
percussion NN NN O
. . . O
Normal NNP NNP O
. . . O
gait NN NN O
. . . O
Assessment NNP NNP O
. . . O
and CC CC O
plan NN NN O
70 CD CD I-AGE
yr NN NN O
F NN NN O
with IN IN O
confirmed VBD VBD O
Brucella NNP NNP O
bacteremia NN NN O
from IN IN O
May NNP NNP I-DATE
30/31 CD CD I-DATE
2080 CD CD I-DATE
and CC CC O
probable JJ JJ O
Brucella NNP NNP O
diskitis/osteomyelitis NNS NNS O
at IN IN O
the DT DT O
L5/S1 NNP NNP O
level NN NN O
. . . O
She PRP PRP O
. . . O
presented VBN VBN O
with IN IN O
a DT DT O
syndrome NN NN O
of IN IN O
constitutional JJ JJ O
symptoms NNS NNS O
and CC CC O
back RB RB O
pain NN NN O
of IN IN O
3 CD CD O
months NNS NNS O
duration NN NN O
, , , O
and CC CC O
has VBZ VBZ O
improved VBN VBN O
dramatically RB RB O
after IN IN O
2 CD CD O
weeks NNS NNS O
of IN IN O
streptomycin NN NN O
IM NNP NNP O
( ( ( O
. . . O
completed JJ JJ O
) ) ) O
, , , O
rifampin NN NN O
300 CD CD O
mg NN NN O
po NN NN O
tid NN NN O
, , , O
and CC CC O
doxycycline NN NN O
100 CD CD O
mg NN NN O
po NN NN O
bid NN NN O
. . . O
Her PRP$ PRP$ O
. . . O
antibiotics NNS NNS O
started VBD VBD O
on IN IN O
6/4/80 CD CD I-DATE
and CC CC O
will MD MD O
be VB VB O
discontinued VBN VBN O
today NN NN O
1/4/81 CD CD I-DATE
after IN IN O
6 CD CD O
months NNS NNS O
of IN IN O
therapy NN NN O
. . . O
She PRP PRP O
. . . O
was VBD VBD O
counseled JJ JJ O
today NN NN O
that IN IN O
she PRP PRP O
is VBZ VBZ O
to TO TO O
watch VB VB O
out IN IN O
for IN IN O
recurrence NN NN O
of IN IN O
infection NN NN O
, , , O
which WDT WDT O
may MD MD O
include VB VB O
fever NN NN O
, , , O
night NN NN O
sweats NNS NNS O
, , , O
weight NN NN O
loss NN NN O
, , , O
anorexia NN NN O
, , , O
worsening VBG VBG O
back RB RB O
pain NN NN O
, , , O
and CC CC O
fatigue NN NN O
. . . O
She PRP PRP O
. . . O
knows VBZ VBZ O
to TO TO O
contact VB VB O
us PRP PRP O
should MD MD O
this DT DT O
occur VB VB O
. . . O
She PRP PRP O
. . . O
was VBD VBD O
counseled VBN VBN O
to TO TO O
not RB RB O
drink VB VB O
unpasteurized JJ JJ O
camel NN NN O
milk NN NN O
. . . O
In IN IN O
. . . O
addition NN NN O
, , , O
Mrs NNP NNP O
Iles NNP NNP I-PATIENT
is VBZ VBZ O
PPD NNP NNP O
positive JJ JJ O
: : : O
she PRP PRP O
has VBZ VBZ O
completed VBN VBN O
the DT DT O
required VBN VBN O
4 CD CD O
months NNS NNS O
of IN IN O
therapy NN NN O
for IN IN O
latent NN NN O
TB NNP NNP O
( ( ( O
she PRP PRP O
had VBD VBD O
6 CD CD O
months NNS NNS O
) ) ) O
as IN IN O
part NN NN O
of IN IN O
the DT DT O
treatment NN NN O
of IN IN O
her PRP$ PRP$ O
Brucella NNP NNP O
infection NN NN O
. . . O
All DT DT O
. . . O
Allergies NNP NNP O
Reviewed NNP NNP O
Ms NNP NNP O
. . . O
. . . O
Iles NNP NNP I-PATIENT
. . . O
was VBD VBD O
seen VBN VBN O
and CC CC O
examined VBN VBN O
with IN IN O
Dr NNP NNP O
. . . O
Tillman NNP NNP I-DOCTOR
. . . O
. . . O
Her PRP$ PRP$ O
. . . O
back RB RB O
pain NN NN O
, , , O
fevers NNS NNS O
, , , O
and CC CC O
weight NN NN O
loss NN NN O
have VBP VBP O
entirely RB RB O
resolved VBN VBN O
. . . O
She PRP PRP O
. . . O
has VBZ VBZ O
finished VBN VBN O
six CD CD O
months NNS NNS O
of IN IN O
doxy/rif NN NN O
and CC CC O
should MD MD O
stop VB VB O
these DT DT O
medications NNS NNS O
. . . O
We PRP PRP O
. . . O
asked VBD VBD O
her PRP PRP O
to TO TO O
return VB VB O
for IN IN O
any DT DT O
new JJ JJ O
back RB RB O
pain NN NN O
, , , O
fevers NNS NNS O
, , , O
or CC CC O
weight NN NN O
loss NN NN O
. . . O
Todd NNP NNP I-DOCTOR
. . . O
Riley NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
pager NN NN O
#03268 NN NN O
cc NN NN O
. . . O
: : : O
DANIELLE NNP NNP I-DOCTOR
TOMPKINS NNP NNP I-DOCTOR
, , , O
CMC NNP NNP I-HOSPITAL
Internal NNP NNP O
Medicine NNP NNP O
Signed NNP NNP O
. . . O
electronically RB RB O
by IN IN O
Todd NNP NNP I-DOCTOR
Riley NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Document NNP NNP O
. . . O
Status NNP NNP O
: : : O
Final NNP NNP O
   
Record NNP NNP O
date NN NN O
: : : O
2068-01-04 JJ JJ I-DATE
Patient NNP NNP O
. . . O
Name NN NN O
: : : O
JOINER,CAITLIN NNP NNP I-PATIENT
[ NN NN O
MRN NNP NNP O
: : : O
3041038MARY CD CD O
] NN NN O
Date NN NN O
. . . O
of IN IN O
Visit NNP NNP O
: : : O
1/04/2068 CD CD I-DATE
Here RB RB O
. . . O
for IN IN O
Urgent NNP NNP O
Visit NNP NNP O
. . . O
She PRP PRP O
. . . O
felt VBD VBD O
well RB RB O
until IN IN O
yesteday NN NN O
evening NN NN O
. . . O
Noted VBD VBD O
. . . O
that IN IN O
her PRP$ PRP$ O
R NN NN O
ear NN NN O
was VBD VBD O
popping VBG VBG O
and CC CC O
felt VBD VBD O
congested JJ JJ O
. . . O
No DT DT O
. . . O
pain NN NN O
or CC CC O
fever NN NN O
. . . O
Went VBD VBD O
. . . O
to TO TO O
bed NN NN O
feeling NN NN O
relatively RB RB O
well RB RB O
but CC CC O
awoke VBD VBD O
at IN IN O
about IN IN O
3 CD CD O
AM NNP NNP O
dizzy NN NN O
and CC CC O
nauseated JJ JJ O
. . . O
Dizziness NNP NNP O
. . . O
passed VBD VBD O
but CC CC O
she PRP PRP O
remained VBD VBD O
nauseated JJ JJ O
for IN IN O
about IN IN O
an DT DT O
hour NN NN O
and CC CC O
vomited JJ JJ O
white JJ JJ O
spittle NN NN O
. . . O
She PRP PRP O
. . . O
awoke VBD VBD O
this DT DT O
am VBP VBP O
still RB RB O
queezy NN NN O
with IN IN O
small JJ JJ O
amounts NNS NNS O
of IN IN O
vomiting VBG VBG O
spittle NN NN O
. . . O
Her PRP$ PRP$ O
. . . O
temp NN NN O
this DT DT O
am VBP VBP O
was VBD VBD O
98.2 CD CD O
. . . O
Went VBD VBD O
. . . O
back RB RB O
to TO TO O
bed NN NN O
about IN IN O
11 CD CD O
am VBP VBP O
and CC CC O
awoke NN NN O
at IN IN O
one CD CD O
o NN NN O
'clock PRP PRP O
still RB RB O
nauseous JJ JJ O
. . . O
No DT DT O
. . . O
cough NN NN O
, , , O
dysuria NN NN O
. . . O
Foot NN NN O
. . . O
care NN NN O
is VBZ VBZ O
good JJ JJ O
with IN IN O
no DT DT O
ulcers NNS NNS O
. . . O
Efforts NNS NNS O
. . . O
to TO TO O
control VB VB O
nausea NN NN O
in IN IN O
past JJ JJ O
with IN IN O
compazine NN NN O
have VBP VBP O
not RB RB O
been VBN VBN O
successful JJ JJ O
. . . O
She PRP PRP O
. . . O
took VBD VBD O
meds NNS NNS O
including VBG VBG O
15u CD CD O
NPH NNP NNP O
. . . O
Her PRP$ PRP$ O
. . . O
BS NNP NNP O
this DT DT O
am VBP VBP O
was VBD VBD O
170n CD CD O
which WDT WDT O
is VBZ VBZ O
high JJ JJ O
for IN IN O
her PRP PRP O
. . . O
She PRP PRP O
. . . O
has VBZ VBZ O
been VBN VBN O
unable JJ JJ O
to TO TO O
eat VB VB O
anything NN NN O
despite IN IN O
trying VBG VBG O
to TO TO O
eat VB VB O
saltines NNS NNS O
. . . O
Patient NNP NNP O
. . . O
started VBD VBD O
to TO TO O
vomit NN NN O
at IN IN O
the DT DT O
end NN NN O
of IN IN O
exam NN NN O
. . . O
AODM NNP NNP O
. . . O
Type NNP NNP O
1 CD CD O
- : : O
First CD CD O
dx NN NN O
'ed PRP PRP O
in IN IN O
12/25 CD CD I-DATE
when WRB WRB O
she PRP PRP O
presented VBD VBD O
with IN IN O
R NNP NNP O
foot NN NN O
foot NN NN O
osteo NN NN O
in IN IN O
mild JJ JJ O
DKA NNP NNP O
. . . O
She PRP PRP O
. . . O
ended VBD VBD O
up RB RB O
with IN IN O
a DT DT O
TMA NNP NNP O
and CC CC O
is VBZ VBZ O
followed VBN VBN O
now RB RB O
by IN IN O
Dr NNP NNP O
. . . O
Pete NNP NNP I-DOCTOR
. . . O
Quintanar NNP NNP I-DOCTOR
and CC CC O
by IN IN O
Dr NNP NNP O
. . . O
Infant NNP NNP I-DOCTOR
. . . O
Church NNP NNP I-DOCTOR
of IN IN O
surgery NN NN O
. . . O
Last JJ JJ O
. . . O
HgbA1c NNP NNP O
6.4 CD CD O
11/28/67 CD CD I-DATE
. . . O
ROS NNP NNP O
. . . O
Denies NNP NNP O
C NNP NNP O
, , , O
SOB NNP NNP O
, , , O
No DT DT O
GU NNP NNP O
or CC CC O
GI NNP NNP O
sx NN NN O
================ NN NN O
. . . O
HealthMaintenance NNP NNP O
================ SYM SYM O
<< NNP NNP O
. . . O
New NNP NNP O
Item NNP NNP O
>> NNP NNP O
09/14/2066 CD CD I-DATE
Breast NNP NNP O
. . . O
Exam NNP NNP O
08/31/2067 CD CD I-DATE
nl NN NN O
Done VBN VBN O
Cholesterol NNP NNP O
. . . O
08/21/2067 CD CD I-DATE
140 CD CD O
DESIRABLE NNP NNP O
: : : O
< NN NN O
200 CD CD O
HBA1C NNP NNP O
. . . O
11/28/2067 CD CD I-DATE
6.40 CD CD O
Mammogram NNP NNP O
. . . O
08/31/2067 CD CD I-DATE
Done/scheduled NNP NNP O
Microalbumin NNP NNP O
. . . O
05/03/2066 CD CD I-DATE
6 CD CD O
Ophthal NNP NNP O
. . . O
Exam NNP NNP O
08/31/2067 CD CD I-DATE
Done VBN VBN O
elsewhere RB RB O
Dr NNP NNP O
. . . O
J NNP NNP I-DOCTOR
. . . O
Gaines NNP NNP I-DOCTOR
Pap NNP NNP O
. . . O
Smear NNP NNP O
09/14/2066 CD CD I-DATE
Done VBN VBN O
Podiatry NNP NNP O
. . . O
exam NN NN O
08/09/2066 CD CD I-DATE
Dr NNP NNP O
. . . O
Vazquez NNP NNP I-DOCTOR
. . . O
will MD MD O
see VB VB O
q NN NN O
3 CD CD O
months NNS NNS O
Rectal NNP NNP O
. . . O
exam NN NN O
09/14/2066 CD CD I-DATE
neg NN NN O
Sigmoidoscopy NNP NNP O
. . . O
08/31/2067 CD CD I-DATE
Discussed NNP NNP O
with IN IN O
patient NN NN O
. . . O
She PRP PRP O
. . . O
refuses VBZ VBZ O
. . . O
Smoking NNP NNP O
. . . O
status NN NN O
09/14/2066 CD CD I-DATE
Never RB RB O
a DT DT O
smoker NN NN O
Stool NNP NNP O
. . . O
Guaiac NNP NNP O
09/14/2066 CD CD I-DATE
Done VBN VBN O
- - - O
negative JJ JJ O
Tetanus NNP NNP O
. . . O
02/08/2066 CD CD I-DATE
Will MD MD O
do VB VB O
at IN IN O
next JJ JJ O
visit NN NN O
UA-Protein NNP NNP O
. . . O
06/08/2067 CD CD I-DATE
NEGATIVE NNP NNP O
Vision NNP NNP O
. . . O
Exam NNP NNP O
09/13/2066 CD CD I-DATE
no DT DT O
change NN NN O
Dr NNP NNP O
. . . O
Gaines NNP NNP I-DOCTOR
. . . O
, , , O
will MD MD O
see VB VB O
in IN IN O
one CD CD O
year NN NN O
================ CD CD O
. . . O
Problems NNS NNS O
================ SYM SYM O
Foot NN NN O
. . . O
ulcer NN NN O
Diabetes NNP NNP O
. . . O
================ SYM SYM O
. . . O
Allergies NNP NNP O
================ SYM SYM O
NKDA NNP NNP O
. . . O
================ NNP NNP O
. . . O
Medications NNP NNP O
================ SYM SYM O
REGLAN NNP NNP O
. . . O
( ( ( O
METOCLOPRAMIDE NNP NNP O
HCL NNP NNP O
) ) ) O
10MG CD CD O
PO NNP NNP O
BID NNP NNP O
INSULIN NNP NNP O
. . . O
NPH NNP NNP O
HUMAN NNP NNP O
15UNITS CD CD O
SC NNP NNP O
QAM NNP NNP O
ASA NNP NNP O
. . . O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
) ) ) O
325MG CD CD O
1 CD CD O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
CAPTOPRIL NNP NNP O
. . . O
50MG CD CD O
PO NNP NNP O
BID NNP NNP O
* NN NN O
. . . O
ACTOS NNP NNP O
45mg CD CD O
PO NNP NNP O
QD NNP NNP O
LIPITOR NNP NNP O
. . . O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
10MG CD CD O
1 CD CD O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
* NN NN O
. . . O
B/D NNP NNP O
INSULIN NNP NNP O
SYRINGES NNP NNP O
U100 NNP NNP O
29G CD CD O
0.5 CD CD O
ML NNP NNP O
1SYRINGE CD CD O
BID NNP NNP O
PE NNP NNP O
. . . O
: : : O
WD/WN NNP NNP O
in IN IN O
NAD NNP NNP O
HEENT NNP NNP O
. . . O
- : : O
nl NN NN O
though IN IN O
L NNP NNP O
ear NN NN O
partially RB RB O
blocked VBN VBN O
by IN IN O
cerumen NNS NNS O
Nodes NNS NNS O
. . . O
- : : O
w/o NN NN O
Carotids NNP NNP O
. . . O
- : : O
no DT DT O
bruits NNS NNS O
Lungs NNP NNP O
. . . O
- : : O
clear JJ JJ O
to TO TO O
P&A NNP NNP O
Cor NNP NNP O
. . . O
- : : O
RRR NNP NNP O
w/o NN NN O
g SYM SYM O
or CC CC O
m NN NN O
Abd NNP NNP O
. . . O
- : : O
benign NN NN O
Ext NNP NNP O
. . . O
- - - O
no DT DT O
edema NN NN O
U/A NNP NNP O
. . . O
unable JJ JJ O
to TO TO O
give VB VB O
a DT DT O
sample NN NN O
FS NNP NNP O
. . . O
bs NN NN O
- : : O
167 CD CD O
nmg CD CD O
% NN NN O
Due JJ JJ O
. . . O
to TO TO O
inability NN NN O
to TO TO O
keep VB VB O
any DT DT O
fluids NNS NNS O
and CC CC O
food NN NN O
down RB RB O
and CC CC O
the DT DT O
fact NN NN O
that IN IN O
she PRP PRP O
has VBZ VBZ O
already RB RB O
taken VBN VBN O
her PRP$ PRP$ O
Isulin NNP NNP O
we PRP PRP O
will MD MD O
admit VB VB O
for IN IN O
antiemetics NNS NNS O
and CC CC O
IV NNP NNP O
hydration NN NN O
. . . O
I PRP PRP O
. . . O
have VBP VBP O
informed VBN VBN O
Dr NNP NNP O
. . . O
Quintanar NNP NNP I-DOCTOR
. . . O
. . . O
_____________________________ NN NN O
. . . O
_ NN NN O
Yan NNP NNP I-DOCTOR
. . . O
D. NN NN I-DOCTOR
Ball NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
   
Record NNP NNP O
date NN NN O
: : : O
2071-02-03 JJ JJ I-DATE
Patient NNP NNP O
. . . O
Name NN NN O
: : : O
JOINER,CAITLIN NNP NNP I-PATIENT
[ NN NN O
MRN NNP NNP O
: : : O
3041038MARY CD CD O
] NN NN O
Patient NNP NNP O
. . . O
is VBZ VBZ O
overdue JJ JJ O
for IN IN O
an DT DT O
annual JJ JJ O
but CC CC O
comes VBZ VBZ O
in IN IN O
for IN IN O
follow VB VB O
up RP RP O
today NN NN O
. . . O
R NN NN O
. . . O
foot NN NN O
ulcer NN NN O
- : : O
It PRP PRP O
has VBZ VBZ O
been VBN VBN O
present JJ JJ O
on IN IN O
and CC CC O
off IN IN O
for IN IN O
almost RB RB O
2 CD CD O
years NNS NNS O
. . . O
It PRP PRP O
. . . O
has VBZ VBZ O
recently RB RB O
, , , O
over IN IN O
the DT DT O
past JJ JJ O
2 CD CD O
months NNS NNS O
, , , O
recurred JJ JJ O
. . . O
She PRP PRP O
. . . O
is VBZ VBZ O
scheduled VBN VBN O
to TO TO O
see VB VB O
Dr NNP NNP O
. . . O
Vetter NNP NNP I-DOCTOR
. . . O
next JJ JJ O
week NN NN O
. . . O
L NNP NNP O
. . . O
ankle VB VB O
frx NN NN O
- - - O
Healed NNP NNP O
. . . O
Saw VBD VBD O
. . . O
Dr NNP NNP O
. . . O
Youngquist NNP NNP I-DOCTOR
. . . O
in IN IN O
December NNP NNP I-DATE
. . . O
AODM NNP NNP O
. . . O
- : : O
Sees VBZ VBZ O
Dr NNP NNP O
. . . O
Quintanar NNP NNP I-DOCTOR
. . . O
on IN IN O
a DT DT O
regular JJ JJ O
basis NN NN O
. . . O
No DT DT O
. . . O
recent JJ JJ O
HgbA1c NNP NNP O
. . . O
Up IN IN O
. . . O
to TO TO O
date NN NN O
with IN IN O
microalbumin NN NN O
, , , O
LDL NNP NNP O
of IN IN O
61 CD CD O
( ( ( O
10/10/69 CD CD I-DATE
) ) ) O
, , , O
sees VBZ VBZ O
Dr NNP NNP O
. . . O
Vetter NNP NNP I-DOCTOR
. . . O
for IN IN O
foot NN NN O
care NN NN O
q NN NN O
3 CD CD O
months NNS NNS O
, , , O
saw VBD VBD O
Dr NNP NNP O
. . . O
Gaines NNP NNP I-DOCTOR
. . . O
for IN IN O
eye NN NN O
care NN NN O
10/10/69 CD CD I-DATE
, , , O
she PRP PRP O
is VBZ VBZ O
going VBG VBG O
to TO TO O
schedule VB VB O
a DT DT O
f/u NN NN O
. . . O
/ NN NN O
. . . O
on IN IN O
Diovan NNP NNP O
( ( ( O
cough NN NN O
on IN IN O
ACEI NNP NNP O
) ) ) O
and CC CC O
Lipitor NNP NNP O
. . . O
BP NNP NNP O
. . . O
slightly RB RB O
elevated VBD VBD O
at IN IN O
150/70 CD CD O
. . . O
Hearing NNP NNP O
. . . O
losses NNS NNS O
- : : O
Still RB RB O
slightly RB RB O
decreased VBD VBD O
on IN IN O
R NNP NNP O
side NN NN O
. . . O
Abd NNP NNP O
. . . O
sx NN NN O
- : : O
On IN IN O
Reglan NNP NNP O
. . . O
No DT DT O
. . . O
sx NN NN O
. . . O
Soc NNP NNP O
. . . O
Hx NNP NNP O
- : : O
Working NNP NNP O
at IN IN O
JN-International NNP NNP I-ORGANIZATION
Medical NNP NNP I-ORGANIZATION
Corporation NNP NNP I-ORGANIZATION
as IN IN O
a DT DT O
Translator NNP NNP I-PROFESSION
, , , O
on IN IN O
a DT DT O
leave NN NN O
due JJ JJ O
to TO TO O
ankle VB VB O
frx NN NN O
. . . O
Single NNP NNP O
. . . O
, , , O
lives NNS NNS O
with IN IN O
her PRP$ PRP$ O
sister NN NN O
. . . O
Fam NNP NNP O
. . . O
Hx NNP NNP O
- : : O
F NN NN O
deceased JJ JJ O
age NN NN O
62 CD CD I-AGE
from IN IN O
Ca NNP NNP O
of IN IN O
the DT DT O
spine NN NN O
. . . O
M NNP NNP O
. . . O
deceased JJ JJ O
age NN NN O
80's CD CD I-AGE
with IN IN O
CHF NNP NNP O
. . . O
1 CD CD O
. . . O
sister NN NN O
, , , O
healthy JJ JJ O
. . . O
ROS NNP NNP O
. . . O
- : : O
No DT DT O
CP NNP NNP O
or CC CC O
SOB NNP NNP O
. . . O
No DT DT O
. . . O
GI NNP NNP O
or CC CC O
GU NNP NNP O
sx NN NN O
. . . O
All DT DT O
. . . O
other JJ JJ O
systems NNS NNS O
reviewed VBD VBD O
and CC CC O
are VBP VBP O
nl NN NN O
. . . O
Problems NNS NNS O
. . . O
Foot NN NN O
. . . O
ulcer NN NN O
Diabetes NNP NNP O
. . . O
Hearing NNP NNP O
. . . O
impairment NN NN O
: : : O
AD NNP NNP O
Hypertension NNP NNP O
. . . O
Health NNP NNP O
. . . O
Maintenance NNP NNP O
Influenza NNP NNP O
. . . O
Vaccine NNP NNP O
09/25/2070 CD CD I-DATE
at IN IN O
work NN NN O
Breast NNP NNP O
. . . O
Exam NNP NNP O
10/28/2069 CD CD I-DATE
nl NN NN O
Done VBN VBN O
Cholesterol NNP NNP O
. . . O
10/10/2069 CD CD I-DATE
140 CD CD O
DESIRABLE NNP NNP O
: : : O
< NN NN O
200 CD CD O
Rectal NNP NNP O
. . . O
exam NN NN O
09/14/2066 CD CD I-DATE
neg NN NN O
M-alb/creat NNP NNP O
. . . O
ratio NN NN O
06/22/2070 CD CD I-DATE
418.7 CD CD O
Mammogram NNP NNP O
. . . O
10/28/2069 CD CD I-DATE
Done/scheduled NNP NNP O
Pap NNP NNP O
. . . O
Smear NNP NNP O
10/28/2069 CD CD I-DATE
Done VBN VBN O
Stool NNP NNP O
. . . O
Guaiac NNP NNP O
09/14/2066 CD CD I-DATE
Done VBN VBN O
- - - O
negative JJ JJ O
Smoking NNP NNP O
. . . O
status NN NN O
09/14/2066 CD CD I-DATE
Never RB RB O
a DT DT O
smoker NN NN O
Vision NNP NNP O
. . . O
Exam NNP NNP O
09/13/2066 CD CD I-DATE
no DT DT O
change NN NN O
Dr NNP NNP O
. . . O
Gaines NNP NNP I-DOCTOR
. . . O
, , , O
will MD MD O
see VB VB O
in IN IN O
one CD CD O
year NN NN O
Sigmoidoscopy NNP NNP O
. . . O
09/24/2068 CD CD I-DATE
discussed VBN VBN O
with IN IN O
patient NN NN O
. . . O
She PRP PRP O
. . . O
still RB RB O
refuses VBZ VBZ O
UA-Protein NNP NNP O
. . . O
01/11/2070 CD CD I-DATE
2+SAMPLE CD CD O
SENT NNP NNP O
TO TO TO O
HEME NNP NNP O
LAB NNP NNP O
FOR IN IN O
ADDITIONAL JJ JJ O
TESTING NNP NNP O
Colonoscopy NNP NNP O
. . . O
10/28/2069 CD CD I-DATE
ordered VBD VBD O
Ophthal NNP NNP O
. . . O
Exam NNP NNP O
10/10/2069 CD CD I-DATE
Seen VBN VBN O
by IN IN O
Dr NNP NNP O
. . . O
Gaines NNP NNP I-DOCTOR
. . . O
Done VBN VBN O
elsewhere RB RB O
Podiatry NNP NNP O
. . . O
exam NN NN O
09/24/2068 CD CD I-DATE
Saw VBD VBD O
Dr NNP NNP O
. . . O
Vetter NNP NNP I-DOCTOR
. . . O
this DT DT O
AM NNP NNP O
, , , O
every DT DT O
three CD CD O
months NNS NNS O
Urine NNP NNP O
. . . O
Culture NNP NNP O
06/16/2067 CD CD I-DATE
see VB VB O
report NN NN O
in IN IN O
Results NNS NNS O
Td NNP NNP O
. . . O
Booster NNP NNP O
02/08/2066 CD CD I-DATE
Triglycerides NNP NNP O
. . . O
10/10/2069 CD CD I-DATE
68 CD CD O
Cholesterol-LDL NNP NNP O
. . . O
10/10/2069 CD CD I-DATE
61 CD CD O
DESIRABLE NNP NNP O
: : : O
< NN NN O
130 CD CD O
Microalbumin NNP NNP O
. . . O
06/22/2070 CD CD I-DATE
38.1 CD CD O
Bone NNP NNP O
. . . O
Density NNP NNP O
10/28/2069 CD CD I-DATE
Bone NNP NNP O
Density NNP NNP O
scheduled VBD VBD O
today NN NN O
Hct NNP NNP O
. . . O
( ( ( O
Hematocrit NNP NNP O
) ) ) O
06/22/2070 CD CD I-DATE
34.5 CD CD O
Complete NNP NNP O
. . . O
Physical JJ JJ O
Exam NNP NNP O
10/28/2069 CD CD I-DATE
Done VBN VBN O
Cholesterol-HDL NNP NNP O
. . . O
10/10/2069 CD CD I-DATE
65 CD CD O
Hgb NNP NNP O
. . . O
( ( ( O
Hemoglobin NNP NNP O
) ) ) O
06/22/2070 CD CD I-DATE
11.2 CD CD O
HbA1c NNP NNP O
. . . O
06/23/2070 CD CD I-DATE
REFUSED NNP NNP O
A1C NNP NNP O
NOT RB RB O
ORDERED NNP NNP O
<< NNP NNP O
. . . O
New NNP NNP O
Item NNP NNP O
>> NNP NNP O
09/14/2066 CD CD I-DATE
Medications NNP NNP O
. . . O
Diovan NNP NNP O
. . . O
( ( ( O
VALSARTAN NNP NNP O
) ) ) O
320MG CD CD O
, , , O
PO NNP NNP O
QD NNP NNP O
Reglan NNP NNP O
. . . O
( ( ( O
METOCLOPRAMIDE NNP NNP O
Hcl NNP NNP O
) ) ) O
10 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
Insulin NNP NNP O
. . . O
Nph NNP NNP O
Human NNP NNP O
22 CD CD O
UNITS NNP NNP O
SC NNP NNP O
QAM NNP NNP O
Folic NNP NNP O
. . . O
Acid NNP NNP O
1MG CD CD O
, , , O
2 CD CD O
PO NNP NNP O
QD NNP NNP O
Actos NNP NNP O
. . . O
45 CD CD O
mg NN NN O
PO NNP NNP O
QD NNP NNP O
Lipitor NNP NNP O
. . . O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
10MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
Hctz NNP NNP O
. . . O
( ( ( O
HYDROCHLOROTHIAZIDE NNP NNP O
) ) ) O
12.5MG CD CD O
CAPSULE NNP NNP O
take NN NN O
1 CD CD O
Capsule NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Asa NNP NNP O
. . . O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
) ) ) O
81MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Norvasc NNP NNP O
. . . O
( ( ( O
AMLODIPINE NNP NNP O
) ) ) O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
( ( ( O
. . . O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
B/d NNP NNP O
. . . O
INSULIN NNP NNP O
SYRINGES NNP NNP O
U100 NNP NNP O
29G CD CD O
0.5 CD CD O
ML NNP NNP O
1 CD CD O
SYRINGE NNP NNP O
BID NNP NNP O
, , , O
Use NN NN O
bid NN NN O
for IN IN O
insulin NN NN O
injections NNS NNS O
. . . O
2short CD CD O
. . . O
needle NN NN O
0.5 CD CD O
ml NN NN O
b-d NN NN O
Atenolol NNP NNP O
. . . O
75 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
Allergies NNP NNP O
. . . O
NKDA NNP NNP O
. . . O
PE NNP NNP O
. . . O
: : : O
WD/WN NNP NNP O
in IN IN O
NAD NNP NNP O
Vital NNP NNP O
. . . O
Signs NNP NNP O
BP NNP NNP O
. . . O
140/80 CD CD O
, , , O
P NN NN O
72 CD CD O
, , , O
Wt NNP NNP O
276 CD CD O
lb NN NN O
R NN NN O
. . . O
foot NN NN O
- : : O
Erythematous NNP NNP O
, , , O
foul JJ JJ O
smelling VBG VBG O
1st CD CD O
metatarsal NN NN O
ulcer NN NN O
. . . O
Imp NNP NNP O
. . . O
: : : O
Probale NNP NNP O
R NNP NNP O
foot NN NN O
osteo NN NN O
. . . O
Plan NNP NNP O
. . . O
: : : O
Admit NNP NNP O
to TO TO O
Medicine NNP NNP O
Consult NNP NNP O
. . . O
ID NNP NNP O
, , , O
Podiatry NNP NNP O
( ( ( O
Dr NNP NNP O
. . . O
Vetter NNP NNP I-DOCTOR
) ) ) O
and CC CC O
Dr NNP NNP O
. . . O
Quintanar NNP NNP I-DOCTOR
. . . O
Continue NNP NNP O
. . . O
outpatient NN NN O
meds NNS NNS O
_____________________________ NNP NNP O
. . . O
_ NN NN O
Yan NNP NNP I-DOCTOR
. . . O
D. NN NN I-DOCTOR
Ball NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
   
Record NNP NNP O
date NN NN O
: : : O
2069-07-03 JJ JJ I-DATE
R NNP NNP O
. . . O
foot NN NN O
ulcer JJ JJ O
- - - O
Present NNP NNP O
for IN IN O
several JJ JJ O
months NNS NNS O
. . . O
Being VBG VBG O
. . . O
followed VBN VBN O
by IN IN O
Dr NNP NNP O
. . . O
Vetter NNP NNP I-DOCTOR
. . . O
. . . O
Being VBG VBG O
. . . O
fitted JJ JJ O
with IN IN O
for IN IN O
special JJ JJ O
shoes NNS NNS O
tomorrow NN NN O
. . . O
AODM NNP NNP O
. . . O
- : : O
Meds NNP NNP O
reviewed VBD VBD O
. . . O
Will NNP NNP O
. . . O
check VB VB O
HgbA1c NNP NNP O
today NN NN O
. . . O
Last JJ JJ O
. . . O
eye NN NN O
exam NN NN O
09/25/68 CD CD I-DATE
. . . O
Cataracts NNP NNP O
. . . O
noted VBD VBD O
by IN IN O
Dr NNP NNP O
. . . O
Gaines NNP NNP I-DOCTOR
. . . O
. . . O
HBP NNP NNP O
. . . O
- : : O
Borderline NNP NNP O
high JJ JJ O
. . . O
Will MD MD O
. . . O
increase VB VB O
Atenolol NNP NNP O
to TO TO O
50 CD CD O
mg NN NN O
qd NN NN O
. . . O
No DT DT O
. . . O
hypoglycemic JJ JJ O
rxn NN NN O
's POS POS O
. . . O
Problems NNS NNS O
. . . O
Foot NN NN O
. . . O
ulcer NN NN O
Diabetes NNP NNP O
. . . O
Hearing NNP NNP O
. . . O
impairment NN NN O
: : : O
AD NNP NNP O
PE NNP NNP O
. . . O
: : : O
WD/WN NNP NNP O
in IN IN O
NAD NNP NNP O
Flowsheets NNP NNP O
. . . O
BP NNP NNP O
. . . O
144/70 CD CD O
Left NNP NNP O
Arm NNP NNP O
P NN NN O
. . . O
72 CD CD O
Regular NNP NNP O
Ht NNP NNP O
. . . O
68 CD CD O
in IN IN O
. . . O
Wt NNP NNP O
. . . O
245 CD CD O
lb NN NN O
R NN NN O
. . . O
foot NN NN O
- : : O
Ulcer NNP NNP O
on IN IN O
ball NN NN O
of IN IN O
L NNP NNP O
foot NN NN O
clean VB VB O
and CC CC O
granulating VBG VBG O
Plan NNP NNP O
. . . O
: : : O
Increase VB VB O
atenolol NN NN O
to TO TO O
50 CD CD O
mg NN NN O
qd NN NN O
RTC NNP NNP O
. . . O
3 CD CD O
months NNS NNS O
30 CD CD O
min NN NN O
Call NN NN O
. . . O
with IN IN O
BP NNP NNP O
readings NNS NNS O
Check NNP NNP O
. . . O
HgbA1c NNP NNP O
____________________________________________ NN NN O
. . . O
_ NN NN O
Yan NNP NNP I-DOCTOR
. . . O
D. NN NN I-DOCTOR
Ball NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
   
Record NNP NNP O
date NN NN O
: : : O
2072-03-08 NN NN I-DATE
Date NN NN O
. . . O
3/08/72 CD CD I-DATE
Time NNP NNP O
. . . O
1:30am CD CD O
Internal NNP NNP O
. . . O
Medicine NNP NNP O
Admission NNP NNP O
Note NNP NNP O
Patient NNP NNP O
. . . O
: : : O
Joiner NNP NNP I-PATIENT
, , , I-PATIENT
Caitlin NNP NNP I-PATIENT
Medical NNP NNP O
. . . O
Record NNP NNP O
Number NNP NNP O
: : : O
304 CD CD I-MEDICALRECORD
10 CD CD I-MEDICALRECORD
38 CD CD I-MEDICALRECORD
Room NNP NNP O
. . . O
: : : O
M270T NNP NNP O
Date NN NN O
. . . O
of IN IN O
Admission NNP NNP O
: : : O
3/07/72 CD CD I-DATE
Attending NNP NNP O
. . . O
Physician NNP NNP O
: : : O
Yan NNP NNP I-DOCTOR
Ball NNP NNP I-DOCTOR
Admitting NNP NNP O
. . . O
Intern NNP NNP O
: : : O
Nathan NNP NNP I-DOCTOR
France NNP NNP I-DOCTOR
Code NNP NNP O
. . . O
Status NNP NNP O
: : : O
FULL NNP NNP O
Source NNP NNP O
. . . O
: : : O
Patient NNP NNP O
, , , O
Medical NNP NNP O
Record NNP NNP O
ID/CC NNP NNP O
. . . O
: : : O
56yoF CD CD O
. . . O
h/o NN NN O
DM NNP NNP O
w NN NN O
/ NN NN O
peripheral JJ JJ O
neuropathy NN NN O
, , , O
chronic JJ JJ O
R NNP NNP O
foot NN NN O
ulcer NN NN O
p/w NN NN O
n/v NN NN O
, , , O
osteomyelitis NNS NNS O
. . . O
History NN NN O
. . . O
of IN IN O
Present JJ JJ O
Illness NNP NNP O
: : : O
Patient NNP NNP O
. . . O
reports NNS NNS O
that IN IN O
since IN IN O
2d CD CD O
prior RB RB O
to TO TO O
admission NN NN O
, , , O
has VBZ VBZ O
had VBN VBN O
significant JJ JJ O
nausea NN NN O
, , , O
vomiting VBG VBG O
w NN NN O
/ NN NN O
food NN NN O
content NN NN O
, , , O
nonbilious-nonbloody JJ JJ O
emesis NN NN O
. . . O
She PRP PRP O
. . . O
reports NNS NNS O
~ NN NN O
q1h NN NN O
emesis NN NN O
, , , O
anorexia NN NN O
. . . O
In IN IN O
. . . O
the DT DT O
past NN NN O
, , , O
has VBZ VBZ O
had VBN VBN O
similar JJ JJ O
symptoms NNS NNS O
in IN IN O
setting VBG VBG O
of IN IN O
ketoacidosis NN NN O
; : : O
reports NNS NNS O
. . . O
blood NN NN O
sugars NNS NNS O
of IN IN O
390s CD CD O
( ( ( O
the DT DT O
day NN NN O
before IN IN O
it PRP PRP O
had VBD VBD O
been VBN VBN O
in IN IN O
190s CD CD O
range NN NN O
, , , O
normal JJ JJ O
for IN IN O
her PRP$ PRP$ O
) ) ) O
. . . O
Denies NNS NNS O
. . . O
early JJ JJ O
satiety NN NN O
, , , O
but CC CC O
has VBZ VBZ O
had VBN VBN O
nausea/vomiting VBG VBG O
related VBN VBN O
to TO TO O
gastroparesis NNS NNS O
. . . O
Patient NNP NNP O
. . . O
reports NNS NNS O
R NNP NNP O
ventral JJ JJ O
ulcer NN NN O
b/w NN NN O
2nd/3rd CD CD O
metatarsal NN NN O
head NN NN O
since IN IN O
6/71 CD CD I-DATE
. . . O
She PRP PRP O
. . . O
believed VBD VBD O
wound NN NN O
was VBD VBD O
healing VBG VBG O
well RB RB O
; : : O
most RBS RBS O
. . . O
recently RB RB O
, , , O
treating VBG VBG O
w NN NN O
/ NN NN O
dry JJ JJ O
dressings NNS NNS O
changed VBD VBD O
qd NN NN O
. . . O
In IN IN O
. . . O
the DT DT O
ED NNP NNP O
, , , O
VS NNP NNP O
: : : O
T97.8 NNP NNP O
HR92 NNP NNP O
BP136/80 NNP NNP O
RR20 NNP NNP O
O2sat99%RA. NNP NNP O
Exam NNP NNP O
. . . O
was VBD VBD O
remarkable JJ JJ O
for IN IN O
R NNP NNP O
foot NN NN O
ulcer NN NN O
, , , O
now RB RB O
draining VBG VBG O
purulent JJ JJ O
material NN NN O
. . . O
Labs NNP NNP O
. . . O
showed VBD VBD O
normal JJ JJ O
anion NN NN O
gap NN NN O
, , , O
glucose NN NN O
278 CD CD O
, , , O
u/a NN NN O
w NN NN O
/ NN NN O
1 CD CD O
+ NN NN O
ketones NNS NNS O
. . . O
X-ray NNP NNP O
. . . O
of IN IN O
foot NN NN O
demonstrated VBN VBN O
destruction NN NN O
of IN IN O
the DT DT O
2nd CD CD O
metatarsal NN NN O
head NN NN O
on IN IN O
R NNP NNP O
, , , O
compared VBN VBN O
w NN NN O
/ NN NN O
1/72 CD CD I-DATE
. . . O
Patient NNP NNP O
. . . O
was VBD VBD O
given VBN VBN O
vanc/cefepime NN NN O
, , , O
reglan NN NN O
for IN IN O
nausea NN NN O
. . . O
Review NNP NNP O
. . . O
of IN IN O
Systems NNPS NNPS O
: : : O
Significant JJ JJ O
. . . O
R NNP NNP O
buttock NN NN O
pain NN NN O
, , , O
since IN IN O
2d CD CD O
prior RB RB O
, , , O
after IN IN O
lifting VBG VBG O
heavy JJ JJ O
groceries NNS NNS O
, , , O
worse JJR JJR O
w NN NN O
/ NN NN O
straight JJ JJ O
positions NNS NNS O
. . . O
Chills NNP NNP O
. . . O
, , , O
anorexia NN NN O
lost VBD VBD O
110#s CD CD O
attributed VBN VBN O
to TO TO O
diuretics NNS NNS O
for IN IN O
R NNP NNP O
heart NN NN O
failure NN NN O
. . . O
Dry NNP NNP O
. . . O
cough NN NN O
. . . O
Chronic JJ JJ O
. . . O
pruritis NNS NNS O
. . . O
Patient NNP NNP O
. . . O
denies VBZ VBZ O
the DT DT O
following VBG VBG O
symptoms NNS NNS O
. . . O
CONSTIUTIONAL NNP NNP O
. . . O
: : : O
f/r NN NN O
/ NN NN O
HEENT NNP NNP O
. . . O
: : : O
h/a/ear NN NN O
pain/sore NN NN O
throat/rhinorrhea NN NN O
PULM NNP NNP O
. . . O
: : : O
/ NN NN O
SOB/DOE NNP NNP O
CV NNP NNP O
. . . O
: : : O
chest NN NN O
pain/palpitations/LH NN NN O
dness/LOC/PND/LE NN NN O
swelling VBG VBG O
ABD:abd NNP NNP O
. . . O
px/constipation/diarrhea/melena/BPR NN NN O
/ NN NN O
bloating NN NN O
GU NNP NNP O
. . . O
: : : O
dysuria/frequency/urgency NN NN O
SKIN NNP NNP O
. . . O
: : : O
NEURO NNP NNP O
. . . O
: : : O
unilateral JJ JJ O
weakness/paresthesia/dysphasia/dysphagia/visual NN NN O
change NN NN O
. . . O
Past JJ JJ O
. . . O
Medical/Surgical NNP NNP O
History NN NN O
: : : O
DM2 NNP NNP O
. . . O
C/b NNP NNP O
. . . O
neuropathy NN NN O
, , , O
CRI NNP NNP O
, , , O
gastroparesis NN NN O
Denies NNP NNP O
. . . O
retinopathy NN NN O
F/b NNP NNP O
. . . O
Dr NNP NNP O
. . . O
Quintanar NNP NNP I-DOCTOR
. . . O
HTN NNP NNP O
. . . O
Foot NN NN O
. . . O
Ulcers NNP NNP O
- : : O
. . . O
1/71 CD CD I-DATE
amputation NN NN O
of IN IN O
R1 NNP NNP O
, , , O
R2 NNP NNP O
toes NNS NNS O
. . . O
- : : O
. . . O
6/71 CD CD I-DATE
development NN NN O
of IN IN O
neuropathic JJ JJ O
ulcer NN NN O
at IN IN O
metatarsal NN NN O
head NN NN O
of IN IN O
R2 NNP NNP O
. . . O
R NNP NNP O
. . . O
heart NN NN O
failure NN NN O
TTE NNP NNP O
. . . O
: : : O
6/71 CD CD I-DATE
EF NNP NNP O
70 CD CD O
% NN NN O
; : : O
mod/severe JJ JJ O
. . . O
TR NNP NNP O
, , , O
RAD NNP NNP O
, , , O
IVC/hepatic NNP NNP O
veins NNS NNS O
dilated VBN VBN O
. . . O
Dilated NNP NNP O
. . . O
RV NNP NNP O
, , , O
RVSP NNP NNP O
51mmHg CD CD O
Anemia NNP NNP O
. . . O
of IN IN O
Chronic NNP NNP O
Disease NNP NNP O
Allergies NNP NNP O
. . . O
: : : O
NKDA NNP NNP O
. . . O
Medications NNP NNP O
. . . O
: : : O
ASA NNP NNP O
. . . O
81 CD CD O
qd NN NN O
Reglan NNP NNP O
. . . O
10 CD CD O
qd NN NN O
Amlodipine NNP NNP O
. . . O
10 CD CD O
qd NN NN O
Lipitor NNP NNP O
. . . O
10 CD CD O
qhs NN NN O
Atenolol NNP NNP O
. . . O
125 CD CD O
qd NN NN O
Lisinopril NNP NNP O
. . . O
40 CD CD O
qd NN NN O
HCTZ NNP NNP O
. . . O
25 CD CD O
qd NN NN O
Folate NNP NNP O
. . . O
2 CD CD O
qd NN NN O
Insulin NNP NNP O
. . . O
20N CD CD O
qam NN NN O
, , , O
10R CD CD O
qam NN NN O
10R CD CD O
. . . O
qpm NN NN O
Lasix NNP NNP O
. . . O
120mg CD CD O
prn NN NN O
for IN IN O
wt NN NN O
gain NN NN O
K NNP NNP O
. . . O
prn NN NN O
w NN NN O
/ NN NN O
lasix NN NN O
Social NNP NNP O
. . . O
History NN NN O
: : : O
Lives NNS NNS O
. . . O
in IN IN O
Estherville NNP NNP I-CITY
w NN NN O
/ NN NN O
sister NN NN O
. . . O
Translator NNP NNP I-PROFESSION
. . . O
. . . O
TOB NNP NNP O
. . . O
: : : O
none NN NN O
ETOH NNP NNP O
. . . O
: : : O
none NN NN O
ILLICITS NNP NNP O
. . . O
: : : O
none NN NN O
Family NNP NNP O
. . . O
History NN NN O
: : : O
M NNP NNP O
. . . O
: : : O
brain NN NN O
aneurysm NN NN O
F NN NN O
. . . O
: : : O
tumor NN NN O
on IN IN O
spine NN NN O
Uncle NNP NNP O
. . . O
: : : O
DM NNP NNP O
Physical JJ JJ O
. . . O
Examination NNP NNP O
: : : O
GEN NNP NNP O
. . . O
: : : O
mildly RB RB O
uncomfortable JJ JJ O
2/2 CD CD O
nausea NN NN O
, , , O
pain NN NN O
, , , O
NAD NNP NNP O
VS NNP NNP O
. . . O
: : : O
T NN NN O
. . . O
98.0 CD CD O
. . . O
P NN NN O
. . . O
98 CD CD O
. . . O
BP NNP NNP O
. . . O
184/76 CD CD O
. . . O
RR NNP NNP O
. . . O
22 CD CD O
. . . O
O2SAT NNP NNP O
. . . O
98%RA CD CD O
. . . O
HEENT NNP NNP O
. . . O
: : : O
MM NNP NNP O
dry JJ JJ O
, , , O
JVP NNP NNP O
7cm CD CD O
. . . O
PULM NNP NNP O
. . . O
: : : O
CTAB NNP NNP O
CV NNP NNP O
. . . O
: : : O
carotid NN NN O
pulses NNS NNS O
2 CD CD O
+ NN NN O
, , , O
no DT DT O
bruits NNS NNS O
auscultated JJ JJ O
. . . O
RRR NNP NNP O
. . . O
, , , O
S1 NNP NNP O
and CC CC O
S2 NNP NNP O
normal JJ JJ O
. . . O
3/6 CD CD O
. . . O
SM NNP NNP O
heard VBD VBD O
along IN IN O
sternal JJ JJ O
border NN NN O
, , , O
non-radiating JJ JJ O
, , , O
and CC CC O
does VBZ VBZ O
not RB RB O
increase VB VB O
w NN NN O
/ NN NN O
inspiration NN NN O
. . . O
ABD NNP NNP O
. . . O
: : : O
soft JJ JJ O
, , , O
NT/ND/NM/NHSM NNP NNP O
. . . O
BS NNP NNP O
. . . O
active JJ JJ O
BACK NNP NNP O
. . . O
: : : O
no DT DT O
point NN NN O
tenderness NNS NNS O
along IN IN O
spine NN NN O
. . . O
Mild NNP NNP O
. . . O
R NNP NNP O
buttock NN NN O
tenderness NN NN O
. . . O
Negative NNP NNP O
. . . O
straight JJ JJ O
leg NN NN O
raise NN NN O
while IN IN O
in IN IN O
sitting VBG VBG O
position NN NN O
. . . O
EXT NNP NNP O
. . . O
: : : O
bilateral JJ JJ O
legs NNS NNS O
w NN NN O
/ NN NN O
e/o NN NN O
venous JJ JJ O
stasis NN NN O
, , , O
both DT DT O
warm JJ JJ O
to TO TO O
touch VB VB O
, , , O
w NN NN O
/ NN NN O
mild NN NN O
erythema NN NN O
. . . O
Ulcers NNP NNP O
. . . O
on IN IN O
R NNP NNP O
anterior NN NN O
shin NN NN O
, , , O
medial JJ JJ O
shin NN NN O
healing NN NN O
. . . O
Excoriations NNS NNS O
. . . O
especially RB RB O
on IN IN O
R NNP NNP O
below IN IN O
knee NN NN O
. . . O
Ulcer NNP NNP O
. . . O
involving VBG VBG O
R NNP NNP O
foot NN NN O
, , , O
ventral JJ JJ O
surface NN NN O
, , , O
1cm CD CD O
diameter NN NN O
, , , O
at IN IN O
least JJS JJS O
2cm CD CD O
deep JJ JJ O
( ( ( O
unclear JJ JJ O
how WRB WRB O
deep JJ JJ O
it PRP PRP O
goes VBZ VBZ O
) ) ) O
, , , O
no DT DT O
purulent NN NN O
drainage NN NN O
, , , O
mild JJ JJ O
erythema NN NN O
of IN IN O
foot NN NN O
but CC CC O
no DT DT O
evidence NN NN O
for IN IN O
cellulitis NNS NNS O
. . . O
NEURO NNP NNP O
. . . O
: : : O
MS NNP NNP O
. . . O
A&Ox3 NNP NNP O
SKIN NNP NNP O
. . . O
: : : O
no DT DT O
rash NN NN O
, , , O
good JJ JJ O
skin NN NN O
turgor NN NN O
Data NNP NNP O
. . . O
: : : O
NA NNP NNP O
. . . O
136 CD CD O
133(L) CD CD O
K NNP NNP O
. . . O
3.1(L) CD CD O
2.8(L) CD CD O
CL NNP NNP O
. . . O
102 CD CD O
102 CD CD O
CO2 NNP NNP O
. . . O
24.0 CD CD O
22.5(L) CD CD O
BUN NNP NNP O
. . . O
20 CD CD O
23 CD CD O
CRE NNP NNP O
. . . O
1.1 CD CD O
1.2 CD CD O
GLU NNP NNP O
. . . O
278(H) CD CD O
MG NNP NNP O
. . . O
1.3(L) CD CD O
TBILI NNP NNP O
. . . O
1.6(H) CD CD O
DBILI NNP NNP O
. . . O
0.7(H) CD CD O
TP NNP NNP O
. . . O
8.6(H) CD CD O
10.0(H) CD CD O
ALB NNP NNP O
. . . O
3.2(L) CD CD O
GLOB NNP NNP O
. . . O
6.8(H) CD CD O
AMY NNP NNP O
. . . O
25 CD CD O
LIPS NNP NNP O
. . . O
1.5 CD CD O
GGT NNP NNP O
. . . O
PEND NNP NNP O
ALT/SGPT NNP NNP O
. . . O
9 CD CD O
AST/SGOT NNP NNP O
. . . O
17 CD CD O
ALKP NNP NNP O
. . . O
132(H) CD CD O
TBILI NNP NNP O
. . . O
1.6(H) CD CD O
DBILI NNP NNP O
. . . O
0.7(H) CD CD O
CK NNP NNP O
. . . O
113 CD CD O
CK-MB NNP NNP O
. . . O
2.1 CD CD O
Negative NNP NNP O
CKMBRI NNP NNP O
. . . O
see VB VB O
detail NN NN O
TROP-I NNP NNP O
. . . O
Negative NNP NNP O
TROP-T NNP NNP O
. . . O
0.05 CD CD O
FE NNP NNP O
. . . O
PEND NNP NNP O
TIBC NNP NNP O
. . . O
PEND NNP NNP O
FER NNP NNP O
. . . O
PEND NNP NNP O
WBC NNP NNP O
. . . O
17.4(H) CD CD O
18.2(H) CD CD O
RBC NNP NNP O
. . . O
3.79(L) CD CD O
3.99(L) CD CD O
HGB NNP NNP O
. . . O
10.1(L) CD CD O
10.7(L) CD CD O
HCT NNP NNP O
. . . O
29.9(L) CD CD O
31.3(L) CD CD O
MCV NNP NNP O
. . . O
79(L) CD CD O
79(L) CD CD O
MCH NNP NNP O
. . . O
26.7 CD CD O
26.8 CD CD O
MCHC NNP NNP O
. . . O
33.7 CD CD O
34.1 CD CD O
PLT NNP NNP O
. . . O
317 CD CD O
403(H) CD CD O
RDW NNP NNP O
. . . O
14.9(H) CD CD O
14.8(H) CD CD O
DIFFR NNP NNP O
. . . O
Received NNP NNP O
METHOD NNP NNP O
. . . O
Auto NNP NNP O
% NN NN O
. . . O
NEUT NNP NNP O
95(H) CD CD O
% NN NN O
. . . O
LYMPH NNP NNP O
2(L) CD CD O
% NN NN O
. . . O
MONO NNP NNP O
3(L) CD CD O
% NN NN O
. . . O
EOS NNP NNP O
0 CD CD O
% NN NN O
. . . O
BASO NNP NNP O
0 CD CD O
ANEUT NNP NNP O
. . . O
16.57(H) CD CD O
ALYMP NNP NNP O
. . . O
0.32(L) CD CD O
AMONS NNP NNP O
. . . O
0.49(H) CD CD O
AEOSN NNP NNP O
. . . O
0.00(L) CD CD O
ABASOP NNP NNP O
. . . O
0.02 CD CD O
ANISO NNP NNP O
. . . O
None NN NN O
HYPO NNP NNP O
. . . O
None NN NN O
MACRO NNP NNP O
. . . O
None NN NN O
MICRO NNP NNP O
. . . O
1+(H) CD CD O
ESR NNP NNP O
. . . O
126(H) CD CD O
UA-GLUC NNP NNP O
. . . O
1 CD CD O
+ NN NN O
1 CD CD O
+ NN NN O
UA-KET NNP NNP O
. . . O
1 CD CD O
+ NN NN O
Negative NNP NNP O
UA-SPGR NNP NNP O
. . . O
1.015 CD CD O
1.015 CD CD O
UA-BLD NNP NNP O
. . . O
see VB VB O
detail NN NN O
Negative NNP NNP O
UA-PH NNP NNP O
. . . O
8.5 CD CD O
8.5 CD CD O
UA-PROT NNP NNP O
. . . O
2 CD CD O
+ NN NN O
1 CD CD O
+ NN NN O
UA-NIT NNP NNP O
. . . O
Negative NNP NNP O
Negative NNP NNP O
UA-WBC NNP NNP O
. . . O
Negative NNP NNP O
Negative NNP NNP O
HCAST NNP NNP O
. . . O
0-2 NN NN O
0-2 NN NN O
UAS-RBC NNP NNP O
. . . O
10-20 JJ JJ O
5-10 JJ JJ O
UAS-WBC NNP NNP O
. . . O
3-5 JJ JJ O
0-2 JJ JJ O
UAS-BACT NNP NNP O
. . . O
Few JJ JJ O
Negative NNP NNP O
UAS-SQHI NNP NNP O
. . . O
Negative NNP NNP O
Few JJ JJ O
IGG NNP NNP O
. . . O
PEND NNP NNP O
IGA NNP NNP O
. . . O
PEND NNP NNP O
IGM NNP NNP O
. . . O
PEND NNP NNP O
SPEP NNP NNP O
. . . O
PEND NNP NNP O
CRP-MG/L NNP NNP O
. . . O
55.8(HT) CD CD O
Blood NNP NNP O
. . . O
culture NN NN O
x2 NN NN O
pending VBG VBG O
Wound NNP NNP O
. . . O
: : : O
gram NN NN O
stain VB VB O
G NNP NNP O
+ NN NN O
Cocci NNP NNP O
clusters NNS NNS O
, , , O
culture NN NN O
pending VBG VBG O
. . . O
EKG NNP NNP O
. . . O
NSR NNP NNP O
, , , O
LAD NNP NNP O
, , , O
prominent NN NN O
T NN NN O
s VBZ VBZ O
compared VBN VBN O
to TO TO O
previous JJ JJ O
, , , O
resolution NN NN O
of IN IN O
Q NNP NNP O
in IN IN O
III NNP NNP O
. . . O
Impression/Plan NNP NNP O
. . . O
: : : O
56yoF CD CD O
. . . O
h/o NN NN O
complicated VBN VBN O
DM2 NNP NNP O
presents VBZ VBZ O
w NN NN O
/ NN NN O
osteomyelitis NN NN O
of IN IN O
R NNP NNP O
foot NN NN O
. . . O
Nausea/vomiting NNP NNP O
. . . O
likely JJ JJ O
multifactorial NN NN O
: : : O
gastroparesis NN NN O
, , , O
hyperglycemia NN NN O
( ( ( O
though IN IN O
no DT DT O
significant JJ JJ O
ketosis NN NN O
) ) ) O
. . . O
Patient NNP NNP O
. . . O
has VBZ VBZ O
consented VBN VBN O
to TO TO O
TMA NNP NNP O
for IN IN O
treatment NN NN O
of IN IN O
osteomyelitis NNS NNS O
. . . O
NAUSEA/VOMITING NNP NNP O
. . . O
: : : O
symptomatic JJ JJ O
treatment NN NN O
, , , O
r/o NN NN O
gall NN NN O
bladder NN NN O
pathology NN NN O
. . . O
- - - O
. . . O
RUQ NNP NNP O
u/s NN NN O
, , , O
NPO NNP NNP O
p NN NN O
MN NNP NNP O
- : : O
. . . O
zofran NN NN O
8mg CD CD O
q6h NN NN O
prn NN NN O
OSTEOMYELITIS NNP NNP O
. . . O
: : : O
vanc/zosyn NN NN O
for IN IN O
now RB RB O
. . . O
No DT DT O
. . . O
h/o NN NN O
MRSA NNP NNP O
. . . O
F/u NNP NNP O
. . . O
wound NN NN O
culture NN NN O
, , , O
if IN IN O
no DT DT O
MRSA NNP NNP O
, , , O
consider VB VB O
switch NN NN O
to TO TO O
nafcillin NN NN O
. . . O
- - - O
. . . O
good JJ JJ O
pulse NN NN O
to TO TO O
foot NN NN O
, , , O
likely JJ JJ O
w NN NN O
/ NN NN O
have VBP VBP O
reasonable JJ JJ O
healing VBG VBG O
. . . O
Art NNP NNP O
. . . O
LENIS NNP NNP O
of IN IN O
R NNP NNP O
leg NN NN O
. . . O
- - - O
. . . O
TMA NNP NNP O
after IN IN O
stress NN NN O
. . . O
EKG NNP NNP O
. . . O
, , , O
CXR NNP NNP O
, , , O
coags NNS NNS O
, , , O
blood NN NN O
bank NN NN O
sample NN NN O
. . . O
R/o NNP NNP O
. . . O
MI NNP NNP O
, , , O
adenosine NN NN O
MIBI NNP NNP O
for IN IN O
pre-op JJ JJ O
( ( ( O
NPO NNP NNP O
p NN NN O
MN NNP NNP O
, , , O
study NN NN O
has VBZ VBZ O
been VBN VBN O
called VBN VBN O
in IN IN O
) ) ) O
- : : O
. . . O
will MD MD O
need VB VB O
peri-operative JJ JJ O
beta-blockade JJ JJ O
. . . O
DM2 NNP NNP O
. . . O
: : : O
- : : O
. . . O
home NN NN O
regimen NN NN O
for IN IN O
now RB RB O
: : : O
hold VB VB O
R NN NN O
and CC CC O
decrease NN NN O
N NNP NNP O
when WRB WRB O
NPO NNP NNP O
, , , O
start VB VB O
d5w NN NN O
1/2NS CD CD O
+ NN NN O
K NNP NNP O
at IN IN O
125cc/h. CD CD O
regular JJ JJ O
. . . O
insulin NN NN O
sliding VBG VBG O
scale NN NN O
- - - O
. . . O
check NN NN O
A1C NNP NNP O
- : : O
. . . O
will MD MD O
need VB VB O
24h CD CD O
urine NN NN O
albumin NN NN O
; : : O
when WRB WRB O
. . . O
infection NN NN O
has VBZ VBZ O
been VBN VBN O
stabilized VBN VBN O
. . . O
- - - O
. . . O
f/b NN NN O
Dr NNP NNP O
. . . O
Quintanar NNP NNP I-DOCTOR
. . . O
. . . O
- - - O
. . . O
ASA NNP NNP O
, , , O
atenolol NN NN O
, , , O
lisinopril NN NN O
, , , O
statin NN NN O
. . . O
CRI NNP NNP O
. . . O
: : : O
at IN IN O
baseline NN NN O
creatinine NN NN O
- : : O
. . . O
avoid VB VB O
renal JJ JJ O
toxic JJ JJ O
meds NNS NNS O
. . . O
ie NN NN O
. . . O
IV NNP NNP O
contrast NN NN O
, , , O
NSAIDs NNP NNP O
. . . O
- - - O
. . . O
lisinopril NN NN O
. . . O
R NN NN O
. . . O
BUTTOCK NNP NNP O
PAIN NN NN O
: : : O
muscular JJ JJ O
spasm NN NN O
vs NNS NNS O
herniated VBN VBN O
disc NN NN O
- - - O
. . . O
avoid VB VB O
significant JJ JJ O
NSAIDs NNP NNP O
given VBN VBN O
CRI NNP NNP O
- : : O
. . . O
morphine NN NN O
, , , O
percocet NN NN O
. . . O
ANEMIA NNP NNP O
. . . O
: : : O
ACD NNP NNP O
+/- NNP NNP O
Fe NNP NNP O
deficiency NN NN O
. . . O
At IN IN O
. . . O
baseline NN NN O
. . . O
- - - O
. . . O
check NN NN O
fe NN NN O
studies NNS NNS O
ELEVATED NNP NNP O
. . . O
GLOBULIN NNP NNP O
: : : O
likely JJ JJ O
in IN IN O
setting VBG VBG O
of IN IN O
osteomyelitis NNS NNS O
, , , O
chronic JJ JJ O
infection NN NN O
- - - O
. . . O
check NN NN O
SPEP NNP NNP O
ELEVATED NNP NNP O
. . . O
ALK NNP NNP O
PHOS NNP NNP O
: : : O
- : : O
. . . O
likely JJ JJ O
from IN IN O
bone NN NN O
destruction NN NN O
, , , O
check NN NN O
5 CD CD O
NT NNP NNP O
, , , O
RUQ NNP NNP O
u/s NN NN O
. . . O
FEN NNP NNP O
. . . O
: : : O
no DT DT O
conc NN NN O
sweets NNS NNS O
, , , O
no DT DT O
added VBD VBD O
salt NN NN O
, , , O
2000cc CD CD O
fluid JJ JJ O
restriction NN NN O
. . . O
PROPHY NNP NNP O
. . . O
: : : O
nexium NN NN O
, , , O
fragmin NN NN O
5000u CD CD O
sc NN NN O
qd NN NN O
. . . O
CODE NNP NNP O
. . . O
: : : O
FULL NNP NNP O
DISPO NNP NNP O
. . . O
: : : O
depends VBZ VBZ O
on IN IN O
functional JJ JJ O
status NN NN O
after IN IN O
amputations NNS NNS O
. . . O
Likely NNP NNP O
. . . O
home NN NN O
. . . O
_____ NN NN O
. . . O
_ NN NN O
Nathan NNP NNP I-DOCTOR
. . . O
France NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Pager NNP NNP O
. . . O
: : : O
#47980 NN NN O
   
